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ABSTRACT

Breast cancer is a major health concern for women, with only a small percent of the
risk factors currently identified. It has been estimated that environmental factors may
contribute to up to 80% of breast cancer cases. Many environmental carcinogens, such as
polycyclic and halogenated aromatic hydrocarbons (PAHs and HAHs), are proven
mammary carcinogens in animal models. Therefore, these studies were conducted to
elucidate potential roles of PAHs and HAHs in alterations in known signaling pathways in
human mammary epithelial cells (HMEC). Carcinogenic PAHs have previously been
shown to produce sustained alterations in the calcium (Ca2') homeostasis of lymphocytes
Therefore, one objective was to determine if carcinogenic compounds produce alterations
in HMEC Ca2* homeostasis. The carcinogenic PAHs, benzo(a)pyrene (BaP) and 7,12dimethylbenz(a)anthracene (DMBA), both produced sustained alterations in intracellular
Ca2' in HMEC and MCF-10A cell line. Tetrachlorodibenzo-p-dioxin (TCDD) only

\
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produced alterations in Ca"* homeostasis in HMEC at early time points. The second
objective of these studies was to determine if these alterations in Ca2* homeostasis were
involved in alterations in growth factor signaling. TCDD and BaP induced MCF-10A
growth under insulin-deficient (HE) conditions. This growth effect correlated with
increased tyrosine phosphorylation of several proteins in whole cell lysates treated under
HE conditions. The third objective of these studies was to determine if increased growth
of MCF-10A under HE conditions was due to activation of insulin-like growth factor
receptor-I (IGF-IR) and downstream signaling molecules. TCDD and BaP both increased
the tyrosine phosphorylation of IGF-IR 3 subunit, and two downstream signaling
molecules, insulin receptor substrate-1 and She. TCDD increased the activity of the
phosphatidylinositol 3-kinase (PI3K) 3-fold and was more effective than BaP, suggesting a
•

role for activation of PI3K in TCDD- and BaP-induced growth effects. Inhibition of PI3K

i

blocked the TCDD-induced growth of MCF-10A under HE conditions. In conclusion.

a

I

these studies demonstrate that carcinogenic HAHs and PAHs alter Ca2* homeostasis in

|
1
\

HMEC and MCF-10A, an effect which does not correlate with the ability to promote cell
proliferation. Increased cell proliferation of MCF-10A under insulin-deficient conditions

\

I

appears to be due to activation of IGF-IR and downstream signaling molecules by BaP

[

and TCDD.

VI
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INTRODUCTION

ENVIRONMENTAL CARCINOGENESIS
Breast cancer is the second leading cause of cancer deaths in women in the United
States, with a 1 in 8 lifetime risk of developing breast cancer (Miller, 1993). Several risk
factors have been identified, including early menarche, late age of menopause, nulliparity,
and age of first birth, all of which involve an individual’s exposure to endogenous
hormones (Henderson et al., 1988). A number of exogenous factors have been linked to
breast cancer, such as ionizing radiation and electromagnetic fields, polycyclic aromatic
hydrocarbons, heterocyclic amines, herbicides, and pesticides (Davis et al., 1993; Huff et
*

al., 1996; Wolff et al., 1996; Wolff et al., 1993). The extent to which environmental

j

[
i
!-

on the steady rise, a role for environmental factors is suggested, especially in light o f the

|

fact that the known risks factors associated with endogenous and hereditary risk factors

«

only account for 30% of breast cancer cases (Davis et al., 1993; Davis et al., 1994).

t.fc

factors contribute to breast cancer is debated, but with the rate of breast cancer incidence

More than an estimated 300 million tons of chemicals per year, consisting of more
I'
it

than 100,000 different compounds, are being released into the environment (Korte &
Coulston, 1994). In fact, many of the chemicals that are found in the environment have

»

l

been shown to induce or promote mammary cancer in animals (Dunnick et al., 1995).
r

Chemical carcinogens, such as polycyclic and halogenated aromatic hydrocarbons (PAHs
and HAHs), are of particular concern in relation to breast cancer due to the lipophilic

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

nature of these compounds and possible accumulation of high concentrations in fatty
tissue (Falck etal., 1992; Morris & Seifter, 1992; Wolff etal., 1993).
Benzo(a)pyrene (BaP) has been shown to accumulate in human fat at low levels
(20 ppt), although the sample number in this study was relatively low for accurate
determination of population exposure (Obana et al., 1981). Estimating the levels o f a
parent compound, such as BaP, may also not accurately reflect the carcinogenic dose of
PAHs accumulated in fat, due to the fact that PAHs may be readily metabolized in the
breast in vivo. Another study estimates that 97% of the total daily intake of BaP is due to
food chain contamination, with an estimated daily intake of 2.2 pg by the general
population (Hattemer-Frey & Travis, 1991). Exposure to chlorinated hydrocarbons, such
as dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyls (PCBs),
5

!
6
[

through bioconcentration in the food chain continues despite the ban of these compounds
in the 1970s (Travis & Arms, 1987). DDT has been shown to activate growth factor
signaling molecules, resulting in increased human mammary epithelial cell proliferation
(Shen & Novak, 1997). Other chemical carcinogens which are persistent in the
environment, such as PCBs, PAHs and HAHs, have all been shown to be associated with
increased breast cancer risk in humans (Falck et al., 1992; Huff et al., 1994; Manz et al.,
1991). Overall, it is likely that chemical carcinogens, which we encounter daily in the
environment, contribute to the etiology of breast cancer, but to what degree is not well
understood.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Tetrachlorodibenzo-p-dioxin - TCDD
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contaminant that
is produced during the synthesis of many halogenated aromatic compounds. TCDD is a
chemical carcinogen that is a very potent tumor promoter in animal models, but has
virtually no initiating activity (Lucier etal., 1991; Pitot & Sirica, 1980; Poland &
Knutson, 1982). While the effects of TCDD in humans is debated, studies have shown
that long-term exposure to TCDD and other organochlorines elevate the risk for breast
cancer (Huff et al., 1994; Manz et al., 1991).
The mechanism of action, especially in relation to enzyme induction, of TCDD at
the molecular level is well understood. TCDD binds with high affinity (KD=10'10 M) to a
cytosolic receptor, the aryl hydrocarbon receptor (Ah receptor or AhR) (Poland et al.,
1976), which causes dissociation of two heat shock proteins (hsp90) with subsequent
translocation of the ligand bound AhR to the nucleus (Henry & Gasiewicz, 1993).
TCDD-AhR complexes associate with Ah receptor nuclear translocator protein (ARNT),
forming a heteromeric-DNA-binding complex (AhR-ARNT) (Pollenz et al., 1994). The
liganded AhR-ARNT complex then binds to xenobiotic response elements (XREs) in the
promoter regions of responsive genes and induces the transcription of these genes
(Denison et al., 1988). The cytochrome P450s CYP1 A l/2 and 1B1, are three genes
which undergo transcriptional activation by AhR-ARNT complex binding (Thomas et al.,
1983; Tritscher et al., 1992; Whitlock et al., 1989). CYP 1A1/2 and 1B1 are xenobiotic
metabolizing enzymes, that can metabolize polycyclic aromatic hydrocarbons to reactive
and potent metabolites, contributing to the carcinogenicity of these compounds (Nebert &
Jensen, 1979; Nebert & Jones, 1989). Polycyclic aromatic hydrocarbons and some

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

polychlorinated biphenyls are able to bind the Ah receptor, resulting in transcriptional
activation of responsive genes, but not as potently as TCDD (Goldstein & Safe, 1989;
Kafafi et al., 1993). Previous studies have shown a strong correlation between the
binding affinity of compounds to the AhR and their ability to induce toxicity (Goldstein
& Safe, 1989; Poland & Knutson, 1982; Safe, 1986; Safe, 1994).
Metabolism o f PAHs
Expression of P450 1A1 and 1B1 genes has been shown in human mammary
samples, while P450 IA2 is primarily a hepatic enzyme (Shimada et al., 1996). It has
been generally accepted that 1A1 is one of the primary enzymes responsible for
metabolism of carcinogenic PAHs in both animal models and humans (Guengerich,
1988). P450 1B1 has been shown to be expressed in many of the same tissues as 1A l,
I
I

and both are highly inducible in response to PAHs and TCDD, indicating that IB 1 could

|

also play an important role in carcinogenic PAH metabolism as well (Savas et al., 1994;

|
r
[
1

Shen et al., 1994; Shimada et al., 1996; Sutter et al., 1994). Studies by several labs have

f
£
I

(Bartley et al., 1982; Christou et al., 1995; Gould et al., 1986; Leadon et al., 1988; Moore

c

shown that P450 1A1 and 1B1 metabolism of PAHs occurs in the mammary gland

et al., 1986; Stampfer et al., 1981). Stampfer et al. (1981) showed that not only did

i
i.

[

human mammary epithelial cells (HMEC) metabolize BaP to the ultimate carcinogenic

1

metabolite 7,8-diol-9,10-epoxide, but mammary fibroblasts produced BaP diol-epoxide
metabolites as well. In comparing rat and human mammary epithelial cell metabolism of
BaP and 7,12-dimethylbenz(a)anthracene (DMBA), HMEC preferentially metabolized
BaP over DMBA to mutagenic metabolites (Gould et al., 1986; Moore et al., 1986).
Christou et al. (1995) showed that, in the rat mammary epithelial system (RMEC), 1Al

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

\

enzyme activity was induced by PAH or TCDD treatment, while 1B1 was active at low
levels after induction, and preferentially metabolized DMBA. IB 1 was found to be
selectively expressed in rat mammary stromal fibroblasts at low constitutive levels, but
was highly inducible by both benzo(a)anthracene (BA) and TCDD. It is thought that
fibroblastic contamination of RMEC cultures is responsible for the observed 1B1 activity.
Constitutive expression of 1B1 is also seen in HMEC, which is mainly responsible for
DMBA metabolism in this system as well, an effect also believed to be due to fibroblast
contamination in human primary cultures (Larsen & Jefcoate, 1997). Of interest, human
1B1 expressed in yeast was shown to preferentially activate the procarcinogens (+/-)BaP7,8-diol and DMBA-3,4-diol over the parent compounds (Shimada et al., 1996).
I
|
t

TCDD Signaling
Many of the toxic effects of TCDD have been well characterized, but its role as a

|

tumor promoter is less well understood, due in part to the complex nature of tumor

|

promotion. The tumor promoting capability of TCDD and related congeners may be

j|'

related to their ability to alter growth factor signaling components and induce

£
I
i:

(EGFR) signaling pathway has been studied by several labs. TCDD has been shown to

|

decrease epidermal growth factor (EGF) binding, and increase phosphorylation of the

I
|
i

transcription factors. The effect of TCDD on the epidermal growth factor receptor

EGFR in rat hepatic plasma membrane (Lin et al., 1991; Madhukar et al., 1984), decrease
membrane EGFR levels in rat hepatic tissue (Sewall et al., 1995) and decrease EGFR
binding affinity in human keratinocytes (Hudson et al., 1985; Hudson et al., 1986).
Alterations in other growth factor signaling pathways induced by TCDD treatment
include decreased breast cancer cell growth by production of transforming growth factor

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

I

P (TGF-P) (Vogel & Abel, 1995) and inhibition of insulin-induced responses of MCF-7
(Liu & Safe, 1996). Modulation of estrogen receptor levels (Romkes et al., 1987;
Umbreit & Gallo, 1988) and c-erb-A (Bombick et al., 1988) have also been observed as a
result of TCDD. Some of TCDD’s effects have been demonstrated to occur in an AhRindependent manner, such as protein kinase and phospholipase C activation (Beebe et al.,
1990; Bombick et al., 1985), and effects on plasma membranes (Matsumura et al., 1984).
BaP has been shown to have similar effects as TCDD on alterations in the EGFR
signaling pathway. BaP decreased EGF binding, down-regulated EGFR levels and
decreased EGFR in placental cells (Guyda et al., 1990; Zhang & Shiverick, 1997). BaP,
DMBA, BA, and 3-methylcholanthrene (3-MC) all decreased the binding affinity of
EGFR for EGF in mouse fibroblasts, an effect not produced by exposure to BaP-7,8-dioli

i
|

9,10-epoxide (BPDE) (Ivanovic & Weinstein, 1982). The significance of BaP- and

*t

TCDD-induced alterations on EGFR signaling and other growth factor signaling in

|j.
I
j

relation to tumor promotion is not known, but such changes could result in alterations in

I
i
I
j

cell proliferation.
The induction of transcription factors and the regulation of gene expression are
the ultimate events that link growth factor signaling pathways to cell proliferation.
Induction of immediate-early genes, such as members of the Fos and Jun families that

i

i

dimerize to form the transcription factor AP-1, may prove to be important in tumor
promotion (Su & Karin, 1996). Puga et al. (1992) demonstrated that treatment o f mouse
hepatoma cells with TCDD and BaP caused an increase in mRNA levels of the
immediate-early genes c-fos, c-jun, junB and junD and an increase in AP-l-DNA binding

6
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activity, with induction of c-fos and junB occurring independently o f AhR and ARNT.
Analysis of the various regulatory sequences activated by TCDD revealed that activation
o f c-fos expression occurs independently of AhR-ARNT complex formation (Hoffer et
al., 1996). In cells that lacked AhR AhR and ARNT were shown to be necessary for
stimulation of expression plasmids containing AhR response elements (AREs) motifs, but
serum response element (SRE)-containing expression plasmids were stimulated equally
well by TCDD whether or not AhR and ARNT were coexpressed. This suggests that
TCDD can induce expression of genes that are normally induced by growth factors in an
AhR-independent manner (Hoffer et al., 1996). Enan and Matsumura (1995) showed that
TCDD is able to cause rapid increases in protein kinase activation in an AhR-dependent
fashion, but without transcriptional activation, and causes stimulation of mitogen
activated protein kinase (MAPK) and protein tyrosine kinases in an equally rapid manner,
indicating that TCDD activates protein kinase mediated growth factor signaling
pathways.
|
f

AhR-dependent effects of TCDD may be related to regulation of growth factor
signaling pathways. Serum-stimulation of growth arrested cells results in increased AhR
expression, in a manner similar to the increased expression induced by ligand-activated
growth factors and v-src oncoprotein (Vaziri et al., 1996). This demonstrates that growth
factor-dependent regulation of AhR may influence the magnitude of ligand-induced
activation of AhR. If there are variable amounts of AhR expressed due to different
growth factor treatments, then AhR activation may effect growth factor signaling
pathways in unique ways, although the aforementioned studies have demonstrated a role
for AhR-independent effects of TCDD in relation to its role as a tumor promoter.
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TCDD-induced oxidative stress may lead to transcription factor activation. The
TCDD-inducible enzymes CYP 1Al and 1A2, which possess arachidonic acid
epoxygenase activity, may generate arachidonate metabolites responsible for the
elevation of the pro-oxidant status of a cell. TCDD-induced expression of a reporter
gene was shown to be dependent on NF-kB activation, an effect abolished by N-acetyl-Lcysteine (Yao et al.,1995). Use of a P450 CYP 1A1 defective cell line, c37, showed that
TCDD-drived expression of a reporter gene was dependent on CYP 1A l activity (Yao et
al., 1995). Therefore, it is likely that oxidative stress, possibly caused by CYP 1A ldriven production of thiol-sensitive reactive oxygen species, contributes to NF-kBinduced gene expression (Yao et al., 1995).
Polycyclic Aromatic Hydrocarbons (PAHs)
|
c-

Polycyclic aromatic hydrocarbons are another class of chemical carcinogens that
are environmentally prevalent compounds. PAHs are formed as by-products of
combustion, generated from engine exhaust, coal-fired power plants, environmental
tobacco smoke, and wood or coal combustion (El-Bayoumy, 1992; Hammerle et al.,
1994; Lofroth, 1989; Lofroth et al., 1991; Moller et al., 1985). Exposure to PAHs occurs
through a variety of occupational, environmental and dietary sources. As mentioned
previously, a person may consume up to 2.2 pg of BaP daily, from bioaccumulation of
the compound in food (Hattemer-Frey & Travis, 1991). Ingestion of BaP as a by-product
of char-broiled foods may amount to as much as 20 pg, while smokers may inhale 0.4-0.8
pg of BaP daily (El-Bayoumy, 1992; Hoffmann & Hecht, 1990; Lijinsky, 1991). PAHs
are well known carcinogens, whose initiating activity have been well characterized

8
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(Peltonen & Dipple, 1995). Many PAHs are metabolized by P450 enzymes to more polar
and water-soluble compounds, as part of the body’s detoxifying process, but some of
these compounds are metabolized to more potent, electrophilic metabolites, that act as
ultimate carcinogens. For example, the potent, naturally occurring carcinogen, BaP,
undergoes metabolic activation by P450 enzymes, first being metabolized to a 7,8epoxide, then undergoing metabolism by epoxide hydrolase to form the trans-7,8dihydrodiol-BaP, and finally P450-epoxidation to form the ultimate carcinogen 7,8-diol9,10-epoxide-BaP (Sims et al., 1974). It has been shown that bay-region dihydrodiol
epoxides of several hydrocarbons with R,S,S,R stereochemistry are primarily responsible
for the tumorigenic action and DNA binding activity (Koreeda et al., 1978). The
principle adduct formed by these bay region dihydrodiol epoxides is almost exclusively
with deoxyguanosine, but R,S,S,R enantiomers of DMBA, a synthetic PAH, also form
adducts with deoxyadenosine (Jerina et al., 1986).
PAHs are complete carcinogens, and as described above, have well characterized
initiating activity. It is the role of PAHs as promoters/progressors, that is less
understood. In examining the role that PAHs may play in breast cancer, several studies
point to a potentially important role that these lipophilic carcinogens may play in relation
to human breast carcinoma development. It has been shown that PAHs induce mammary
tumors in rodents (Ethier & Ullrich, 1982). In human mammary epithelial cells
(HMEC), the naturally occurring BaP is more mutagenic than the synthetic DMBA,
which is in contrast to observations in the RMEC system (Gould et al., 1986). PAHDNA adduct formation and oxidative DNA damage from metabolic activation of BaP in
HMEC has been well documented by several labs (Bartley et al., 1982; Leadon et al.,
9
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1988; Leadon et al., 1995; Stampfer et al., 1981). The use of the HMEC model to study
growth control and proliferation of mammary cells and how these functions become
altered after exposure to compounds such as HAHs and PAHs, may lead to understanding
the progression of normal mammary cells to malignant cells.
MULTISTAGE CARCINOGENESIS
Traditionally, the pathogenesis of neoplasia consists of three stages beginning
with initiation, followed by promotion and progression (Foulds, 1954; Pitot & Dragan,
1991). Initiation and progression involve structural changes in the DNA and are
irreversible events. Exposure o f normal cells to chemical, physical or microbial
carcinogens causes genetic changes, leading to altered responsiveness in the initiated cell
;

(Haugen & Harris, 1990; Slaga, 1983). DNA adducts are a commonly observed

t

characteristic o f initiation by chemical carcinogens, leading to base transitions,

f

transversions and small deletions (Shubik, 1950). The initiated cell may have altered
responsiveness to signals that regulate the growth and maturation of the cell. Initiated
cells may be less responsive to negative regulators of cell proliferation, inducers of
terminal differentiation, and programmed cell death (Moses et al., 1990; Parkinson, 1985;

I
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Parkinson et al., 1983; Pfeifer et al., 1989; Rotello et al., 1991).
Promotion involves clonal expansion of initiated cells by reversible enhancement

r

or repression of gene expression mediated via receptors for the specific promoting agent,
with continued dependence on the presence of the promoting agent (Glauert et al., 1986;
Neveu et al., 1990; Schulte-Hermann et al., 1983; Takematsu et al., 1983). The stage of
progression involves genetic alterations resulting from karyotypic instability, irreversible
changes in gene expression, and selection of neoplastic cells for optimal growth
10
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phenotype/genotype in response to the cellular environment (Boyd & Barrett, 1990;
Foulds, 1954; Nowell, 1976; Rowley, 1990; Schimke, 1990). Neoplastic cells are
characterized by unrestrained cell proliferation, increased invasiveness and metastic
capacity, and biochemical changes due to the irreversible DNA damage (Pitot & Dragan,
1996). Complete carcinogens are chemicals possessing the ability to initiate, promote
and progress normal cells to neoplastic cells (Pitot & Dragan, 1996). PAHs are an
example of a family of chemical carcinogens which can act as complete carcinogens.
Oncogenes and Tumor Suppressor Genes
Critical DNA targets in the multi-stage process of carcinogenesis are proto
oncogenes and tumor suppressor genes. Proto-oncogenes are present in the DNA of all
cells and are essential for regulation of cell growth (Risse et al., 1990; Walker, 1989).
These proto-oncogenes, when inappropriately activated to oncogenes, lead to
*

dysregulation of cell proliferation and differentiation pathways, a step that is critical to
the process o f transformation (Balmain & Brown, 1988). Activation of proto-oncogenes
to oncogenes may occur due to base substitution mutations, chromosomal translocation

f

and gene amplification (Brown et al., 1990; Lavi, 1981). Mutation of the Ha-ras proto-

t

oncogene is a common target in chemically-induced mammary carcinogenesis in rodent

»

|
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models (Brown et al., 1990; Cha et a i, 1994; Kumar et al., 1990). Amplification of

j

overexpression of erbB-2 is found in 10% o f cases (Slamon et al., 1987). A common

proto-oncogene erbB-2 is found in 9-30% of all primary breast cancers, and

feature of these gene targets in breast cancer, is that both are involved in signal
transduction in growth factor receptor signaling pathways. Thus, it appears that growth

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

t

factor signaling pathways are targets for mutations and signal transduction dysregulation
by tumor promoters.
Tumor suppressor genes are also normal functioning genes in a cell, whose
inactivation results in loss of function and allows neoplastic transformation to occur
(Cavanee et al., 1983; Harris et al. ', 1969; Knudson, 1971; Knudson & Strong, 1972).
Mutations occurring within tumor suppressor genes are more likely to contribute to the
process of transformation, due to the fact that a point mutation in only a few specific
codons can cause activation of proto-oncogenes, but the normal function of a tumor
suppressor gene is more easily disrupted by such mutations. Targeted disruption of the
p53 tumor suppressor gene, which guards a cell cycle checkpoint, is seen in 50% of all
cancer cases, emphasizing the fact that these types of mutations may predominate in the
!
f
S
I
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transformation process (Vogelstein et al., 1989).

I

(Pitot & Dragan, 1995). Promoting agents exert their effects through alterations in gene

Tumor Promotion
The stage of promotion is perhaps the hardest to study, due to it’s complex nature

s.

I

expression, primarily by perturbing signal transduction pathways that confer a selective

*

growth advantage to initiated cells over that of surrounding non-initiated ceils (Pitot,

|

1990). The mechanism of altering gene expression may be mediated through specific

|

receptors, possibly explaining why many promoting agents are tissue specific (Pitot &
Dragan, 1996). The mechanism by which promoting agents enhance cell proliferation is
not known, but the principal mechanism linking signal transduction to the cell cycle is
through protein phosphorylation and dephosphorylation by protein kinases and
phosphatases (Bohmann, 1990). Increased levels of receptors or components o f a signal
12
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t
transduction pathway, as well as mutations in cyclins, cyclin-dependent kinases (cdks) or
transcription factors could all lead to promotion of initiated cells (Kumar et al., 1989;
Pfeifer et al., 1989; Spom & Todaro, 1980).
Classic tumor promoters, such as phorbol esters, exert their effects through
modulation of protein kinase C (PKC) activity in a manner analogous to its normal
activator, diacyl glycerol (DAG). Phorbol esters increase the affinity of PKC for calcium
(Ca2+) at physiological concentrations (for the a , P and y isozymes), without the
necessary IP3-dependent increase in intracellular Ca2+ (Nishizuka, 1984; Nishizuka,
1986). Activation of PKC involves translocation from the cytosolic fraction of a cell to
the membrane fraction, leading to increased activity and, eventually, down-modulation.
!

PKC is an important regulator of cell growth and differentiation in many cell systems,
including HMEC (Jaken, 1990).

w
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Another tumor promoter, thapsigargin, is considered non-classical, because it does
not directly activate PKC (Hakii et al., 1986; Thastrup et al., 1990; Thastrup et al., 1989),

fe

i
f

but rather causes inhibition of calcium ATPases of the sarcoplasmic and endoplasmic

|

reticulum (SERCA) of cells, resulting in a persistent elevation of intracellular Ca .

t

Interestingly, thapsigargin treatment of rat pituitary cells results in redistribution of the

I

!

calcium-independent PKCs, instead of expected effects on calcium-dependent PKCs (a,

r

1
I

P, y) (Kiley et al., 1992). The molecular mechanisms of thapsigargin as a tumor promoter

i

are just beginning to become elucidated. It has been shown that thapsigargin-induced
release of intracellular Ca2+activates MAPK in a Raf-1-dependent manner, independent
of PKC or Ca2+influx (Chao et al., 1992; Chao et al., 1994). Thapsigargin has also been

13
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shown to rapidly activate src kinase activity, leading to activation o f both Raf-1 and MAP
kinase (Chao et al., 1997). Other studies have investigated effects o f thapsigargin on
gene induction, showing that thapsigargin treatment leads to rapid expression of both cjun and c-fos proto-oncogenes, without activation of PKC (Schonthal et al., 1991).
Calcium Signaling
Calcium is not only an important activator of signaling molecules that appear to
be involved in tumor promotion and progression, but it is a very commonly utilized
second messenger in many signaling systems, including growth factor signaling pathways
(Cole & Kohn, 1994). Most of the calcium in non-excitable cells is sequestered and
stored in the endoplasmic reticulum (ER) (Clapham, 1995). As shown in Figure 1, a
common mechanism for release of calcium from these stores is by formation of inositol
1,4,5-trisphosphate (IP3), resulting from phospholipase C (PLC) cleavage of
phosphatidylinositol bisphosphate (PIP2) into IP3 and DAG (Berridge & Irvine, 1989).
IP3 can then bind to specific receptors on the ER membrane and cause release of
intracellular Ca2+stores from the ER. This process is highly regulated by pumps in the
ER membrane (SERCA pumps), which use ATP to pump Ca2+back into the ER. This is
obviously an important mechanism for cellular homeostasis, emphasized by the fact that
it requires the expenditure of ATP and that failure to repool Ca2+ in the ER can lead to
persistence of this second messenger (it is not metabolized). Elevation of intracellular
Ca2+ is associated with apoptosis (Nicotera et al., 1994).
Both the G protein-coupled receptor class of seven transmembrane-spanning
receptors (GCRs) and receptor tyrosine kinases (RTKs) activate PLC p and y isozymes,

14
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Figure 1. Epidermal growth factor receptor signal transduction leading to cell
proliferation in human mammary epithelial cells.
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respectively, leading to IPs formation (Clapham, 1995). With regard to human mammary
epithelial cell signaling, epidermal growth factor (EGF) binds to a specific growth factor
receptor (EGFR), leading to PLC-yl activation, via Src homology 2 (SH2) domain
binding to phosphotyrosines on the cytoplasmic tails of the receptor (Carpenter & Cohen,
1990). Activation of PKC, downstream of EGFR, also appears to be important in this
growth factor signaling pathway, since PKC can negatively regulate EGFR by threonine
phosphorylation and PLC-yl by serine phosphorylation (Park et al., 1992), keeping in
check mitogenic signaling.
Activation of the ras/Raf-l/MAPK pathway occurs downstream of activated
EGFR, and other growth factor signaling pathways such as the insulin-like growth factor
signaling pathway. Initially, growth factor receptor bound protein 2 (Grb2) and
•
f

[
*

mammalian son of sevenless (mSos) complex associates with a phosphotyrosine residue on
the cytoplasmic tail of the EGFR through the SH2 domain on Grb2. mSos then functions
as a guanine-nucleotide-releasing protein in converting inactive ras to the active GTPbound form by nucleotide exchange (Egan et al., 1993), with subsequent activation of the
ras/Raf-l/MAPK cascade of signaling. Activation of the ras pathway in relation to the

r

insulin-like signaling pathway occurs in a similar manner.
ROLE OF GROWTH FACTOR SIGNALING

;

Hormones and growth factors are the most important factors regulating cellular
proliferation and differentiation, two processes that are critically altered in malignant
transformation. It is evident that the ability of a neoplastic cell to proliferate in an
unrestrained manner is a hallmark of transformation. In vitro, there is a decreased
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dependence on exogenous growth factors for the proliferation of neoplastic cells as
compared to normal counterparts. These two observations suggest that neoplastic cells 1)
may overexpress growth factor receptors that have constitutive activity or that high levels
of receptor may sensitize the cell to low levels of growth factor or 2) secrete their own
endogenous growth factors that bind to and activate growth factor receptors already
present on the cell, creating an autocrine loop (Callahan & Salomon, 1993; Ethier, 1995).
For human mammary epithelial cells, the two most important exogenous growth factors
are EGF and insulin-like growth factors (IGFs). Therefore, when investigating how the
proliferation of a normal cell becomes dysregulated, it seems critical to evaluate how the
normal functioning of these growth factor signaling pathways change in the process of
cell transformation.
|
f

Epidermal Growth Factor Receptor
The importance of the EGFR signaling pathway is not only demonstrated for
growth o f human mammary epithelial cells, but alterations in this pathway in breast

i
j
S

carcinomas is well documented. It is well known that the EGFR and the oncogene

f

proto-oncogenes of the erbB family have been identified (erbB-3 and erbB-4), all of

her2/neu/erbB-2 are members of the same growth factor receptor family. Several other

which can form heterodimers, creating unique signaling pathways in breast cancer cells
(Earp et al., 1995; Ethier et al., 1996). Overexpression of either EGFR or erbB-2, or both,
correlates with poorer prognosis in advanced breast cancer (Wright et al., 1989). The
EGFR is expressed in approximately 45% of breast carcinomas and elevated levels of
EGFR are associated with poor tumor differentiation, high tumor grade, aneuploidy, and
a high rate of cell proliferation in patients with breast cancer (Klijn et al., 1992). The
17
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expression of the EGFR ligand, transforming growth factor-a (TGF-a), in transgenic
mice leads to mammary hyperplasia and eventually mammary carcinomas (Sandgren et
al., 1990), suggesting a role for this ligand/receptor interaction in the genesis of
mammary carcinomas.
Recent information suggests that EGFR family members form heterodimers
between family members, and that these heterodimers may form when only one member
o f the pair binds to a ligand (Earp et al., 1995). Heterodimerization may extend the
signal produced by EGFR family members and provide a more potent growth stimulus, as
well as influence downstream signaling, possibly by activating a number of different
pathways in a synergistic manner (Earp et al., 1995). This is in fact illustrated by Ram et
al. (1996), who demonstrated that erbB-2 amplification, overexpression and activation in

i'

£
|

a human breast cancer cell line (21MT-1), resulted in activation of EGF- and IGF-I-like
downstream signals.
About 30% of breast cancers have a hormone-dependent estrogen receptorpositive/epidermal growth factor receptor-negative status (ER+/EGFR-), but a larger
percentage have a hormone-independent (ER-/EGFR+) status, which signifies poorer
prognosis. Only 6-19% of breast cancers have been detected as double positives
(ER+/EGFR+), indicating a clear inverse relationship for the function of these two
receptor signaling pathways in relation to their involvement in breast cancer biology
(Nicholson et al., 1991; Nicolson et al., 1989). The associated poorer prognosis with
EGFR positivity indicates the serious consequences that increased production of EGFR

18
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ligands, or increased EGFR, erbB-2, -3, and -4 expression and activation can have in
relation to breast cancer.
Insulin and Insulin-like Growth Factor Signaling
Another important growth factor pathway, in relation to both normal and
neoplastic mammary cell growth, is the insulin receptor family. Insulin and insulin-like
growth factors are peptide hormones that bind with high affinity to the insulin receptor
(IR) and insulin-like growth factor receptor-I (IGF-IR) respectively (Czech, 1989). While
insulin mediates metabolic functions, as well as growth at supraphysiological
concentration, it is IGF-I that is responsible for the control of cell proliferation o f many
types of cells, all of which are mediated through IGF-IR (Baserga & Rubin, 1993; Lowe,
1991, see Figure 2).
I.

\
I
\
t
'■
t

One main pathway that can lead to cell proliferation is through activation of ras,
by nucleotide exchange of GDP for GTP. Activation of both IGF-IR and IR, as well as
EGFR, can all lead to ras-GTP formation. IR and IGF-IR activation o f ras occurs through
downstream docking molecules, rather than direct interaction of Grb2-Sos to the receptor.
The two primary downstream docking molecules for both IR and IGF-IR are src
homology 2/a-collagen-related protein (She) and insulin receptor substrate-1 (IRS-1).

f
j

Upon ligand stimulation of IR and IGF-IR, tyrosine phosphorylation of a NPXY motif in

|

in the cytoplasmic tail of the the p subunit mediates the interation between the receptor
and IRS-1 or She (Myers et al., 1993; White et al., 1988; Yonezawa et al., 1994). IRS-1
has over 20 tyrosine phosphorylation sites which serve as docking sites for SH2 domain
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Figure 2. Insulin-like growth factor receptor-I signal transduction pathway leading to
cell proliferation in human mammary epithelial cells.
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containing proteins such as Nek (Lee et al., 1993), protein tyrosine phosphatase 2 (PTP2)
(Sun et al., 1993), p85 subunit of phosphatidylinositol 3-kinase (PI3K) (Backer et al.,
1992), and Grb2-Sos (Skolnik et al., 1993). She also binds Grb2-Sos, which then leads to
ras-GDP nucleotide exchange to the active ras-GTP form (Skolnik et al., 1993). She is
the predominant signaling molecule linking both IGF-IR and IR signaling to ras-GTP
formation (Sasaoka et al., 1994; Sasaoka et al., 1996).
Insulin receptor substrate-2 (IRS-2) is another recently discovered substrate for IR
and IGF-IR, which also becomes tyrosine phosphorylated on several sites upon ligand
activation (Sun et al., 1995). It was believed that IRS-2 and IRS-1 have some redundant
functions. Mutational studies conducted in IRS-1 deficient mice have shown that insulin
and IGF-I stimulation of glucose metabolism and growth are reduced by 50-60%, despite
|

that fact that IRS-2 can mediate downstream signal transduction (Araki et al., 1994;

I
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Tamemoto et al., 1994). IRS-1 knockout studies were performed in embryonic fibroblast

;

and 3T3 cell lines. IRS-1 deficiency was associated with a 70-80% reduction in IGF-I-

\
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stimulated cell growth and parallel S-phase entry, inhibition of PI3-kinase activity, and

I

inhibition of induction of immediate-early genes (Bruning et al., 1997). PI3K activity

I

and induction of immediate-early genes could be restored by increased expression o f IRS-

i
I

2 or restored IRS-1 expression, but increased expression of IRS-2 did not restore

I

mitogenesis (Bruning et al., 1997). IRS-1 has also been shown to be required for insulin-

i

and IGF-I-induced cell proliferation in studies using microinjection of anti-IRS-1
antibodies (Rose et al., 1994).
The She family of adapter proteins, consisting of p66, p52 and p46, associate with
and can be activated by EGFR, IR and IGF-IR (Pellici et al., 1992; Pronk et al., 1993;
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Pronk et al., 1994; Sasaoka et al., 1994). The difference between EGF and insulin
activation of She may be reflected in the functionally different domains of She, SH2 and
PTB (phosphotyrosine binding) domains respectively, critical to the signaling events
specific to each growth factor (Ricketts et al., 1996).
The second main pathway leading to cell proliferation in the insulin signaling
pathway involves activation of PI3K. PI3K is a dimer that is composed of an adapter
protein (p85) and a catalytic subunit (pi 10). p85 SH2 domains preferentially bind P-Tyr608 and P-Tyr-939 on IRS-1, with two adjacent YXXM motifs on IRS-1 helping to
determine the specificity of p85 binding to IRS-1 at these sites (Sun et al., 1993). SH2
domain binding of p85 to IRS-1 leads to PI3K activation (Myers et al., 1992). IGF-I
stimulated activation of IGF-IR leads to activation of PI3K through phosphorylation of
IRS-1 (Myers et al., 1993). Substrates for PI3K are phosphatidylinositol (PI),
phosphatidylinositol 4-phosphate (PI 4-P) and phosphatidylinositol 4,5-bisphosphate (PI
4,5-Pj), all of which become phosphorylated on the 3’ position of the inositol ring
(Cantley et al., 1991; Whitman et al., 1988). The resulting products are involved in a
variety of cell functions such as vesicle trafficking, cell adhesion, actin rearrangement,
cell growth and cell survival (Stephens et al., 1993; Toker & Cantley, 1997). 3phosphorylated inositol lipids are resistant to hydrolysis by PLC, but instead are
hydrolyzed by inositol lipid phosphatases (Lips et al., 1989; Serunian et al., 1989;
Wolscholski et al., 1995). The PI3K product, PI 3,4-P2, has been shown to activate a
serine/threonine protein kinase, protein kinase B (Akt/PKB), which is thought to be
involved in protection from apoptosis (Franke et al., 1997). Other products of PI3K have
been shown to be important mediators of mitogenesis mediated by various growth factor
22
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receptors (Varticovski et al., 1994), including platelet derived growth factor receptor (Hu
et al., 1992; Severinsson et al., 1990), colony-stimulating factor 1 (ShurtlefF et al., 1990),
and insulin (Cheatham et al., 1994). Several investigators have shown an association
between EGFR and p85, along with increased PI3K activity following EGF stimulation
(Bjorge et al., 1990; Hu et al., 1992), but these studies were conducted in non-human
systems expressing human EGFR. EGFR lacks the YXXM motif that is necessary for
strong p85-phosphotyrosine association, raising some doubts about the relevance of a role
for EGFR in PI3K activation. PI3K is activated by erbB family member heterodimers
and constitutively activated erbB-2, providing a mechanism for heregulin-induced
proliferation in mammary epithelial cells and growth factor-independent proliferation in
human breast carcinoma cells, respectively (Alimandi et al., 1995; Kim et al., 1994; Ram
& Ethier, 1996; Sotoloffe/a/., 1994).
IGF-IR gene knock-outs have demonstrated two points concerning the importance
of IGF-IR as a growth factor receptor -1) that disruption of IGF-IR inhibits growth under
serum-free conditions even when EGFR is overexpressed (Sell et al., 1994; Sell et al.,
1993) and 2) a ras-independent pathway, not utilized by EGFR, exists that is important
for IGF-IR mitogenesis (Sell et al., 1994). Another indicator of the importance that IGFIR plays in mitogenesis, as well as transformation, is the requirement of IGF-IR for
transformation by overexpressed EGFR, while the reciprocal situation doesn’t require
EGFR for IGF-IR transformation (Coppola et al., 1994; Pietrzkowski et al., 1992).
There are several lines of evidence that point to a role for IGF-IR and insulin- and
IGF-induced signaling in transformation, specifically leading to breast cancer. IGFs have
been shown to be potent mitogens for breast cancer cells in vitro (Osbome et al., 1990;
23
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Osbome et al., 1989; Yee et al., 1988), with IGF-I being a more potent mitogen than
IGF-II (Osbome et al., 1990; Yee et al., 1988). These findings are in agreement with the
binding affinities of IGFs for IGF-IR. It is believed that IGF-I acts in a paracrine manner,
being synthesized by surrounding adipose tissue and stromal cells (Doglio et al., 1987;
Yee et al., 1989). IGF-II may act as both a paracrine and autocrine factor, since mRNA
and protein can be detected in breast cancer cell lines, malignant breast epithelial cells
and stromal cells (Lee et al., 1994; Osbome et al., 1989; Paik, 1992; Quinn et al., 1996;
Yee et al., 1988). IR content and IGF-IR ligand binding is higher in malignant breast
tissue than in normal tissue (Jammes et al., 1992; Papa et al., 1990). 82-87% of breast
cancers have been shown to express IGF-IR (Papa et al., 1993; Peyrat et al., 1990) and
had more circulating IGF-I than healthy age matched controls (Peyrat et al., 1990).
Insulin and IGFs play an important role, along with EGF, in the mitogenesis of
normal human mammary epithelial cells, and a possible role in deregulated growth of
breast cancer cells. Free levels of the mitogens IGF-I and IGF-II are tightly regulated in
the circulation by high affinity binding of insulin-like growth factor binding proteins
(IGFBPs), leaving low levels of the IGFs available for tissue interaction (Jones &
Clemmons, 1995). Levels of IGFs in the body have been shown to decrease in the third
decade of life, in parallel with decreases in growth hormone (GH) (LeRoith, 1992). This
leaves organs, such as the mammary gland, susceptible to xenobiotics that can exploit
signaling through this pathway, whether it is through direct activation by alterations in
downstream signaling molecules or by increased IGF and IGF-IR activity. It is clear that
modulation of IGF-induced mitogenesis could have important implications in tumor
promotion/progression events in the development of breast carcinomas.
24
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Relevant Background Research
Previous research in our lab has investigated the mechanisms by which PAHs
cause immunosuppression in lymphocytes (Archuleta et al., 1993; Davila et al., 1995;
Davila et al., 1996; Krieger et al., 1994; Krieger et al., 1995; Mounho et al., 1997). The
immunosuppressive properties of PAHs correlates well with their carcinogenic potential
in rodent in vivo models (White, 1986). These findings suggest that there may be
common mechanisms of PAH-induced immunotoxicity and cancer. One possible
mechanism involves alterations in Ca2+-dependent signaling pathways. In lymphocytes
these alterations may result in immunosuppression, whereas changes in cell growth
leading to promotion of initiated cells could result from alterations in growth factor
signaling pathways that utilize Ca2+ as a second messenger.
Krieger et al. (1994) found that Ca2+ elevation in a T cell line (HPB-ALL) was
’

produced rapidly by weakly immunosuppressive PAHs, while the strongest
immunosuppressive agents produced sustained Ca2+(at least 4 hours). Genistein, a

|
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protein tyrosine kinase inhibitor, inhibited the rapid PAH-induced Ca2+elevation, while
PKC inhibitors, staurosporine and calphostin C, had no effect on PAH-induced Ca2+
elevation (Krieger et al., 1994), suggesting that rapid alterations in intracellular Ca2+ may
be due to activation of tyrosine kinases. Immunosuppressive PAHs were also found to

<

inhibit calcium-ATPases (SERCA) on the ER, possibly indicating a mechanism for the
sustained alterations in Ca2+observed (Krieger et al., 1995). The manner in which PAHs
inhibit SERCA is similar to the mechanism by which the tumor promoter thapsigargin
inhibits SERCA, leading to persistent alterations in intracellular Ca2+ (Thastrup et al.,
1990; Thastrup et al., 1989).
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Archuleta et al. (1993) found in the same T cell line (HPB-ALL), that DMBA was
able to induce a rapid and sustained Ca2+elevation, tyrosine phosphorylation of PLC- yl,
and formation of IP3, in a manner similar to anti-CD3/CD4 activation in T cells
(Archuleta et al., 1993). The ability to mimic antigen-receptor activation in T cells may
be due to an increase in tyrosine kinase activity, since it was found that DMBA induced a
2-fold increase in the activity of the T cell receptor associated src-family kinases Fyn and
Lck (Archuleta et al., 1993).
Since PAHs induce alterations in intracellular Ca2+and do so by
activating/mimicking Ca2+-dependent pathways in relation to their immunosuppressive
properties, it is possible that pathways that utilize Ca2+as a second messenger in HMEC
may also be affected by such compounds in relation to their carcinogenic properties. One
such important pathway that leads to increases in Ca2+ through PIP2 hydrolysis is the
EGFR pathway. Activation of both the T cell receptor and the EGFR result in PLC-yl
activation. This in turn leads to IP3 and DAG formation, resulting in release of Ca2+ from
the ER in a IP3-dependent manner (Figure 3). Archuleta et al. (1993) showed that DMBA
induced activation of PLC-yl, followed by increased IP3 formation and increased
intracellular Ca2+. Therefore, in the HMEC model system, activation of PLC-yl by
carcinogenic PAHs could lead to IP3 and DAG formation, in a manner that could result in
increased intracellular Ca2+ and subsequent PKC activation. Although second messenger
activation of PKC does not typically result in the prolonged activation, like the effect
induced by phorbol esters, in combination with other effects in the cell, sustained
increases in Ca2+ may lead to sustained activation of Ca2+-dependent PKCs. Carcinogenic
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PAHs also have been shown to inhibit SERCA pumps on the ER, leading to persistent
elevation of intracellular Ca2+(Krieger et al., 1995). The tumor promoter thapsigargin
also has been shown to inhibit SERCA pumps as its mechanism of action (Figure 3).
Therefore, PAH-induced inhibition of SERCA pumps could also lead to persistent
elevation of intracellular Ca2+with subsequent activation of the ras/Raf-l/MAPK
pathway of proliferation and/or activation of immediate early genes, c-fos and c-jun, as
has been demonstrated for the mechanism of action of thapsigargin (Chao et al., 1992;
Chao et al., 1994; Schonthal et al., 1991). Activation o f ras followed by increased
expression c-fos and c-jun is one of the important pathways downstream of EGFR that
can lead to cell proliferation and/or differentiation. If PAHs can inhibit SERCA in a
manner analogous to thapsigargin, then any observed sustained alterations in intracellular
r
(
f
|
i

Ca2+ in HMEC may result in ras/MAPK activation, leading to increased cell proliferation
by activation of post-receptor signaling molecules. PAH-induced activation of another

I

post-receptor signaling molecule in the EGFR pathway, src, could also lead to cell

jj

proliferation.
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Figure 3. A possible model for alterations in Ca2+ homeostasis in human mammary
epithelial cells induced by PAHs, in relation to tumor promotion.

28a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

©
o

Ills
Q . l.

(g

O

L U O i l Q^

28b

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Proliferation

O'
LU

RESEARCH OBJECTIVES

Assessing the ability of PAHs to alter Ca2+homeostasis, specifically in relation to
growth factor signaling pathways, may be important in determining how these complete
carcinogens function as promoters/progressors. Therefore, one of the primary research
objectives was to determine if carcinogenic PAHs alter Ca2+homeostasis in a sustained
maimer, in comparison to noncarcinogenic PAHs. If carcinogenic PAHs are able to alter
Ca2+ homeostasis in HMEC in a specific manner, this may point to a mechanism by
which PAHs act as complete carcinogens, in a manner similar to that seen for
immunosuppressive PAHs in lymphocytes.
In lymphocytes, alterations in Ca2+homeostasis have previously been shown to be
i
'
I
I
£
:

associated with activation of tyrosine kinases, as determined by src-family kinase

i

activation and use of the tyrosine kinase inhibitor genistein to abrogate intracellular Ca2+
elevation (Archuleta et al., 1993; Krieger et al., 1994). Therefore, a second objective of

|

these studies was to determine if alteration of intracellular Ca2+ correlates with the ability

J

of carcinogenic compounds to activate tyrosine kinases, as assessed by examination o f

■

changes in the tyrosine phosphorylation status of various proteins. Activation of the src

I

kinase in the EGFR pathway of signaling by PAHs could contribute to changes in

I

downstream signaling leading to mitogenesis.
Activation of tyrosine kinases is likely to be involved in activation of cell
proliferation pathways in HMEC, since activation of kinases is a primary mechanism by
which growth factor receptor signaling pathways propagate downstream signaling.
Consequently, a third objective of these studies is to correlate alterations in intracellular
29
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signaling (Ca2+and tyrosine kinase activation) and the ability of carcinogenic compounds
to promote growth of HMEC and MCF-10A cells.
Use of BaP metabolites and a-naphthoflavone in some of these studies will
suggest whether P450 driven metabolism of PAHs contributes to alterations in signaling
in a significant manner. It is already established that metabolism of PAHs to electrophilic
metabolites is necessary for initiation events, but the role of metabolism in
promotion/progression events is not well understood (Jerina et al., 1986; Koreeda et al.,
1978; Peltonen & Dipple, 1995).
Assessment of TCDD as a modulator of cell signaling pathways in HMEC and
MCF-10A may provide clues as to the mechanism of action of this tumor promoter and
give insight as to the role that AhR plays in initiating these effects. Use of normal cells
for these studies is critical for understanding how the changes in normal cell signaling
leads to a transformed phenotype induced by chemical carcinogens.
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HYPOTHESIS

Carcinogenic PAHs are able to mimic and/or activate Ca2+-dependent growth factor
receptor signaling pathways in HMEC and MCF-10A, representing possible
alterations in normal cell signaling that may contribute to promotion/progression
events in human breast cancer.

t
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SPECIFIC AIMS
1. Characterize alterations in intracellular Ca2+in primary human mammary
epithelial cells induced by treatment with the PAHs BaP, DMBA, BeP and
Anthracene and the potent HAH, TCDD.
a. Evaluate whether carcinogenic PAHs, BaP and DMBA, produce significant
alterations in Ca2+ homeostasis, as compared to noncarcinogenic PAHs, BeP and
Anthracene.
b. Conduct time-course studies with BaP, DMBA and TCDD in order to
determine the kinetics of disruption of Ca2+homeostasis.
c. Assess the importance of PAH metabolism in relation to the sustained
alterations in Ca2+homeostasis by co-incubation with ANF, a partial P450
inhibitor.
d. Evaluate the ability of BaP to alter growth factor signaling pathways by
assessment o f growth after long-term treatment of HMEC under varying

i
!
I
;

concentrations of EGF.
2. Characterize alterations in intracellular Ca2+in the human mammary epithelial
cell line MCF-10A, and compare the ability of PAHs and/or HAHs to alter cell
proliferation under growth factor defined conditions in relation to their ability
to produce alterations in Ca2+signaling.
a. Determine structure activity relationships for a series o f 8 carcinogenic and
noncarcinogenic PAHs in relations to sustained alterations in Ca2+homeostasis.
b. Assess the dose response relationship and time course of action of the potent
PAHs, BaP, 3-MC and DMBA.
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c. Determine the time course of action of the BaP metabolite, 7,8-dihydrodiol,
and the HAH, TCDD.
d. Determine whether metabolism of BaP and BaP-7,8-dihydrodiol, by co
incubation with ANF, contributes to the sustained alterations in Ca2+homeostasis.
e. Determine whether BaP and TCDD can alter MCF-10A cell growth under
growth factor defined conditions, in relation to their ability to alter Ca2+
homeostasis.
f. Assess whether BaP and TCDD treatment leads to alterations in tyrosine
phosphorylation of proteins, in relation to their growth promoting effects, by antiphosphotyrosine blotting o f whole cell lysates.
I

g. Determine if BaP and BaP-7,8-dihydrodiol treatment leads to changes in

|
\r
\
j
I
I
•

tyrosine phosphorylation o f proteins by activation of kinase, as assessed by
Herbimycin A pretreatment.
3. Examine the effects of PAHs and HAHs on the insulin-like growth factor
signaling pathway, in relation to the ability of these compounds to alter cell growth

!
I
'

a. Determine whether BaP and TCDD treatment can lead to changes in the

t

|
i
‘

tyrosine phosphorylation status of the (3 subunit of the mitogenic IGF-IR.
b. Assess whether a downstream signaling molecule of both the EGFR and IGF-

;

IR, She, undergoes tyrosine phosphorylation specifically due to BaP and TCDD
treatment, in comparison to the noncarcinogenic compounds, BeP and 2,2’,5,5’tetrachlorobipheny 1.
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c. Examine the tyrosine phosphorylation status o f the specific downstream
substrate of the IGF-IR, insulin receptor substrate-1 (IRS-1), induced by BaP and
TCDD treatment.
d. Assess changes in the activity of PI3K, the downstream enzyme activated
through IRS-1 interaction, induced by BaP and TCDD treatment.
e. Determine if PI3K activation by TCDD is necessary for its mitogenic effects
under insulin deficient conditions by use of a PI3K inhibitor, LY294002, in
growth studies.
f. Compare the growth promoting effects of two PCBs, the AhR ligand
3,3’,4,4’,5-pentachlorobiphenyl, and the non-AhR ligand 2,2’,5,5’tetrachlorobiphenyl, to those of TCDD under growth factor defined conditions to
{
-

assess the role the AhR may play in signal transduction leading to increased

i

mitogenesis.

i
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CHAPTER I

Carcinogenic Polycyclic Aromatic Hydrocarbons Increase Intracellular Ca2+ and
Cell Proliferation in Primary Human Mammary Epithelial Cells

BACKGROUND AND SIGNIFICANCE

Polycyclic aromatic hydrocarbons (PAHs) are well known complete chemical
carcinogens capable of tumor initiation, promotion, and progression (Pitot & Dragan,
1996). PAHs induce mammary tumors in rodents and perhaps other species (Ethier,
1985). The mechanism by which PAHs initiate tumor formation has been studied for
many years, and it is generally believed that PAHs must be metabolized to reactive
intermediates to exert their carcinogenic action (Miller, 1970). The mechanisms whereby
PAHs cause tumor promotion and progression have been less well-studied.
In recent years, it has been demonstrated that PAHs, such as 7,12dimethylbenz(a)anthracene (DMBA) and benzo(a)pyrene (BaP), have important effects
on Ca2+ signaling pathways in murine and human lymphoid cells (Burchiel et al., 1991;
Davila et al., 1995). It has been demonstrated that PAHs increase intracellular levels of
free Ca2+ in human lymphoid cells by activating src protein tyrosine kinases associated
with the T cell receptor leading to IP3-dependent Ca2+mobilization from intracellular
stores (Archuleta et al., 1993). We have also recently shown that PAHs are capable of
inhibiting Ca2+reuptake pumps present in the endoplasmic reticulum of lymphocytes,
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which may be one mechanism by which PAHs produce sustained elevation of
intracellular Ca2+ (Krieger et al., 1995).
There are several lines of evidence that alterations in Ca2+ homeostasis in HMEC
by be important in normal and neoplastic cell growth. Cell proliferation and growth of
mammary epithelial cells is dependent upon the action of several growth factors,
including epidermal growth factor (EGF) and insulin-like growth factors (IGF) (Ethier et
al., 1990; Ethier et al., 1987; Stampfer & Yaswen, 1993). Overproduction or activation
of growth factor receptors may be associated with neoplastic progression (Aaronson,
1991). Following receptor binding, many growth factors, such as EGF, stimulate tyrosine
phosphorylation leading to the release o f intracellular Ca2+(Glenney, 1992). Signaling
through the epidermal growth factor receptor (EGFR) leads to calcium mobilization and
ray-dependent Ca2+ influx in cells overexpressing the EGFR (Tinhofer et al., 1996).
A hallmark of malignant transformation, progression and metastasis is aberrant
signal transduction, and a common regulator of different pathways o f signal transduction
is Ca2+homeostasis (Cole & Kohn, 1994). Elevated Ca2+concentrations in cultures of
basal epidermal keratinocytes and mouse keratinocytes results in the modification of cell
phenotype characteristic of tumor promoters (Slaga et al., 1982; Trump & Berzesky,
1987). Ca2+plays an important role in regulating epithelial cell proliferation, by
activating protein kinase C (PKC), leading to protein phosphorylation and cell
proliferation (Durham & Walton, 1982; Whitfield etal., 1981). Therefore it seems likely
that if an agent is able to alter Ca2+homeostasis by inducing sustained elevation of
intracellular Ca2+, that pathways leading to cell proliferation may be activated or
deregulated.
36
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Based upon previous studies in our laboratory that have shown that carcinogenic
and immunosuppressive PAHs alter lymphocyte Ca2+ homeostasis and mimic certain Ca2+
signaling pathways, the present studies were performed to determine whether
carcinogenic PAHs alter Ca2+homeostasis in primary cultures of HMEC, perhaps
contributing to the tumor promoting or signaling properties of PAHs in normal or
transformed breast cells.

*
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MATERIALS AND METHODS

Chemicals and Reagents. All chemicals or reagents used were from Sigma
Chemical Co. (St. Louis, MO), unless otherwise indicated. The PAHs used in this study
included: benzo(a)pyrene (BaP), benzo(e)pyrene (BeP), 7,12-dimethylbenz(a)anthracene
(DMBA), anthracene (ANT), and a-naphthoflavone (ANF). These chemicals were
prepared weekly as stock solutions in anhydrous tissue culture grade dimethyl sulphoxide
(DMSO) and were protected from light. The final culture concentration of the DMSO in
all experiments was 0.1% or less. The PAHs used were >95% purity as assessed by the
manufacturer. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased from
Cambridge Isotopes Labs (Andover, MA) at >99% purity.
Growth of Primary Cultures of Human Mammary Epithelial Cells (HMEC).
Primary cultures were obtained from tissue derived from reduction mammoplasties, and
processed as previously described (Ethier et al., 1993). Briefly, the tissue was initially
washed with sterile PBS containing 100 units/ml penicillin/streptomycin (BioWhittaker,
Walkersville, MD) and fungizone (GIBCO BRL, Grand Island, NY), and then minced
into small (1 mm3) pieces using sterile scalpels (#10 or #12 blade). Minced tissue was
then placed in a collagenase solution containing 200 units collagenase type Ill/ml
(Worthington Biochemical Co, Freehold, NJ) and dispase at 1 mg/ml, prepared in
Medium 199 with 20 ml of digestion solution/gram of tissue used. Tissue was placed in a
shaking water bath (37°C) overnight at 65 x g. The digested solution was spun at 750 x g
for 10 min and the supernatant saved to collect single cells. Organoids were resuspended
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ill 10-20 ml of cold Ml 99 and spun and washed three more times. Organoids were then
resuspended in plating medium, which consists of Ham’s F-12 supplemented with 5%
FBS, 1 mg/ml hydrocortisone, 10 ng/ml EGF (Collaborative Biomedical, Bedford, MA),
100 ng/ml cholera toxin, 5 mg/ml insulin, 100 units/ml penicillin/streptomycin. Ceils
were grown in 75 cm2 flasks (Co-Star, Cambridge, MA) in a 5% C 02 incubator and
passaged every 4-5 days. For these experiments, passage 3-5 cells were cultured in 6well plates (Coming, Coming, NY) and grown to confluence before harvested (approx. 3
x 105 cells per sample).
Analysis of Intracellular Free Ca2+in HMEC by Flow Cytometry. Samples
were measured for levels of intracellular free Ca2+using an Elite flow cytometer (Coulter,
Haleah, FL), as previously described (Novak & Rabinovitch, 1994). Briefly, samples
were trypsinized (0.25% trypsin, ImM EDTA, Gibco BRL, Grand Island, NY), spun
down and resuspended in complete media containing 4 pM Fluo-3 AM and 9 pM Fura
Red AM (Molecular Probes, Eugene, OR) in a volume of 100-400 pL and incubated at
37°C for 2 h, with cells being resuspended every 20 min to ensure proper loading. For
kinetics experiments, cells were loaded with the Ca2+chelating dyes during the last 2 h of
PAH treatment. Analysis o f the green/red mean-channel fluorescence ratio was
determined as an indicator o f intracellular Ca2+. It was determined that the presence of
PAHs in the samples did not interfere with the fluorescent signal received.
XTT Assay. The XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5[(phenylamino)-carbonyl]-2H-tetrazolium hydroxide) assay was used to quantitate cell
proliferation as previously described (Scudiero et al., 1988). Briefly, cells were plated
into 12-well plates (Coming, Coming, NY) at a density of 6 x 103cells/well and allowed
39
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to attach in complete media for 24 h. Treatments were added after 24 h and media
changed every two days. XTT solution was prepared on the day of use at 1 mg/ml in
prewarmed media without serum. 5 mM PMS solution was prepared in PBS and stored at
4° C for 3 months, protected from light. For a 0.025 mM PMS-XTT solution, 25 pi of
stock 5 mM PMS solution was added to 5 ml of fresh XTT solution. After wells had been
aspirated, 350 pi of XTT-PMS solution was added per well and allowed to incubate at
37°C for 4 hr. Plates were then agitated, and a 50 pi aliquot put into a 96-well plate for
analysis. Samples were read at 450 n mona Bio-Tek EL309 microplate autoreader.
Statistical Design and Analysis. Data were analyzed for statistical differences
(p<.05) between control and treated groups using SigmaStat statistical software (Jandel
Scientific, San Rafael, CA). ANOVA followed by Dunnett’s t-tests were performed on
f

sample means, with use of a Mann-Whitney test when equal variance test failed.

t
J
ji
Ii
i

J

i
if
t

40

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

RESULTS

Carcinogenic PAHs Produce Dose-Dependent Increases in Intracellular Ca2+
in HMEC. Experiments were performed in which carcinogenic and non-carcinogenic
PAHs were evaluated by flow cytometric analysis for their ability to alter Ca2+
homeostasis in HMEC. In seven experiments with cells obtained from different donors,
treatment of HMEC for 18 h with four different PAHs in culture demonstrated that
carcinogenic PAHs (BaP and DMBA) significantly increased intracellular Ca2+in a dosedependent manner (Figure 4, upper left, upper right). All donor cells treated overnight
with BaP, a carcinogenic PAH, induced a statistically significant increased in
1

intracellular Ca2+ at both 0.3 and 3 pM, except for treatment of donor #5 at 0.3 pM

t

(Figure 4, upper left).

*

Four of the donor cells treated overnight with 0.3 and 3 pM DMBA, a synthetic
carcinogenic PAH, showed a good dose-response relationship for Ca2+ mobilization. At

I

the highest dose (3 pM), DMBA induced a statistically significant increase in
intracellular Ca2+in cells obtained from four donors (Figure 5, upper right). Cells from

i

two donors demonstrated very little difference in Ca2+channel shift between the 0.3 and 3
pM DMBA treatment (donors #4 and #6, Figure 5, upper right). Cells from one donor
demonstrated a strong Ca2+response at both doses of DMBA (donor #4), and the other
donor showed little response to either dose (donor #6).
Overnight treatment with BeP, a noncarcinogenic PAH, induced a poor doseresponse relationship in all donor cells tested (Figure 4, lower left). Only the highest
dose tested (3 pM) yielded a Ca2+change that was statistically significant in 1 of 6 donor
41
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cells tested (donor #2, Figure 4, lower left). There was variability in the response to BeP
treatment between donor cells, possibly due to differences between in d iv id u a l s , but
overall the effect of BeP did not produce significant changes in intracellular Ca2+.
Treatment with another noncarcinogenic PAH, anthracene, showed no dose-response
between the 0.3 and 3 pM anthracene treatments, and none of the donors tested showed a
significant increase in intracellular Ca2+ (Figure 4, lower right). All four of the PAHs
were also evaluated at a concentration of 0.03 pM, but none of the PAHs produced a
statistically significant increase in intracellular Ca2+ in HMEC at this concentration (data
not shown).
The average increase in intracellular Ca2++ SE produced by PAHs for all donors
tested is shown in Figure 5. BaP was the only PAH that produced a statistically
■

significant increase in intracellular Ca2+ at the 0.3 pM concentration, whereas both BaP

i

!
t

and DMBA increased intracellular Ca2+ at the 3 pM concentration. In contrast, BeP and

I

Ca2+at the 0.3 or 3 pM concentrations.

|

?
f
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anthracene were not found to produce a statistically significant increase in intracellular

Time-Dependence of BaP, DMBA, and TCDD Ca2+Elevation in HMEC.

J*

\
I
■

Examination of the time-dependence of Ca2+elevation revealed that 3 pM DMBA and 0.1
pM TCDD caused a more rapid and transient increase in intracellular Ca2+ than did 3 pM
BaP (Figure 6). The results shown in Figure 6 are from a representative experiment that
was conducted three times with cells from different donors. DMBA and BaP produced a
statistically significant increase in intracellular Ca2+ at 2 h and 6 h of exposure. However,
the time-dependence of the response was different in that the DMB A-induced Ca2+
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elevation peaked early, whereas the BaP-induced effect increased with time and appeared
to be still increasing at the 18 h time point. Later time points were evaluated in other
experiments, where it was found that BaP maintained elevated levels of intracellular Ca2+
for several days (data not shown).
TCDD also increased intracellular Ca2+ in HMEC, with an apparent maximal
response occurring at approximately 2 h. In a series of studies with cells from five
donors, it was found that the Ca2+response of HMEC to TCDD was somewhat more
variable than the responses to DMBA and BaP (data not shown).
a-Naphthoflavone reduces the Ca2+Signaling Response to BaP, but not
DMBA or TCDD. a-naphthoflavone (ANF) is an inhibitor of P450 1Al and 1A2
*

enzymes that are responsible for the conversion of BaP and DMBA to reactive

;

metabolites (Thakker et al., 1985). BaP, DMBA, and TCDD are all ligands of the Ah
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receptor, and ANF may also be a partial antagonist of the Ah receptor in some species
(Nebert, 1989). Therefore, it was of interest to determine whether ANF could alter the

5
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Ca2+ response of HMEC to these agents. As shown in Figure 7,10 pM ANF was found to
produce a small increase in intracellular Ca2+in HMEC treated for 18 h. However, when

I
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■
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10 jj,M ANF was co-incubated with 3 jiM BaP, ANF was found to reduce the Ca2+-

i

(

elevating effects o f BaP. ANF did not significantly decrease the Ca2+response induced

i

\
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by 3 pM DMBA or 0.1 pM TCDD. These results are consistent with the hypothesis that
BaP metabolites are responsible for the late and sustained Ca2+-elevating effects of BaP.
BaP Increases Cell Proliferation in HMEC. Since activation of the EGFR
signaling pathways are important for inducing cell proliferation in HMEC, activation of
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which can lead to mobilization of intracellular Ca2+ through PLC-y, the potential
mitogenic effects of BaP in HMEC culture were investigated. Cultures of HMEC were
treated with 0.03,0.3 or 3 pM BaP in the absence or presence (0-10 ng/ml) EGF for 4
days. Results of the cell proliferation assay showed that 3 pM BaP increased HMEC cell
numbers in all treatment groups with or without EGF (Figure 8). The effects of 3 pM
BaP, the dose which was shown previously to cause sustained Ca2+ alterations, appeared
to be most effective in increasing cell proliferation in the presence of 1 and 5 ng/ml EGF.
The 0.3 pM concentration of BaP also caused a significant increase in cell proliferation at
5 ng/ml EGF. The results of XTT assays were verified by direct examination of cell
cultures and isolated nuclei cell counts.
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Figure 4. Sustained alterations in intracellular Ca2+induced by carcinogenic and
noncarcinogenic PAHs. HMEC were incubated overnight (18 h) in culture with 0.3 or 3
pM PAH and were then analyzed by flow cytometry for intracellular Ca2+, as measured
by changes in the fluorescence ratio of two Ca2+chelating dyes, 4pM Fluo-3 AM and
9pM Fura Red AM for cells obtained from seven individual donors. Data is expressed as
the change in the mean channel fluorescence ratio compared to DMSO (0.1%, solvent
I
\

control) treated samples, Mean ± SE. All experiments were conducted in quadruplicates.

r.
j

* indicates a significant (p < .05) increase in Ca2+compared to DMSO controls. Mean

i
js

channel fluorescence ratio numbers for DMSO controls are as follows: Donor #2 289 +/-

|

7, Donor #3 388 +/- 10, Donor #4 441 +/- 9, Donor #5 362 +/- 17, Donor #6 270 +/- 6,
Donor #7 245+/- 11.
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#8

Figure 5. Mean change in fluorescence channel ratio (Mean + SE) for the seven donors
examined in Figure 4. * indicates a significant (p < .05) increase in Ca2+ compared to
\k
I

DMSO controls. The actual mean channel fluorescence ratio for DMSO control is 333.
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Figure 6. Time course for changes in intracellular Ca2+ in HMEC produced by DMBA (3
pM), BaP (3 pM), and TCDD (0.1 pM). Cells were loaded with Fluo-3/AM and FuraRed/AM during the last two hours of PAH exposure and analyzed for fluorescence
changes, as described in Fig. 4 and Methods. Results are Mean ± SE for an experiment
that is representative of three experiments conducted on samples from different donors.
Quadruplicate samples were used for analysis. * Indicates a significant increase in Ca2+ as
compared to DMSO solvent control (p <.05). The mean channel fluorescence ratio for
DMSO control is as follows: 2 h control 403 +/- 3, 6 h control 478 +/- 15,18 h control
353 +/- 16.
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Figure 7. a-naphthoflavone-induced alterations in sustained elevation of intracellular
Ca2+ in HMEC. HMEC were treated for 18 h with 10 pM a-naphthoflavone (ANF) in the
presence or absence of 3 pM BaP, 3 pM DMBA or 0.1 pM TCDD. Results shown are
|

the mean Ca2+ fluorescence (FL) channel ratio. Results shown are for two experiments

\

with different donors, samples analyzed in quadruplicate. * Indicates a significant

t(

\

difference between control (DMSO) and PAH-treated samples, + Indicates a significant

\

difference between ANF treated samples and non-ANF treated samples (p < .05).

r

i
i

|
'f

t
i

i

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

500

Calcium

FL Ratio Mean C h a n n e l

480 I

460 -

DMSO
I ANF (10 |jM)

440 420 400 380 360 340 320 300 280 260 240 -

220

-

CONTROL

BaP 3 mM DMBA 3 mM TCDD 0.1 \iM

48b

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 8. BaP-induced alterations in HMEC proliferation. BaP (0.03,0.3 or 3 pM) was
added to HMEC cultures in the presence or absence (0-10 ng/ml) of EGF for 4 days and
cell proliferation was quantitated using the XTT colorimetric assay, as described in
Methods. These are representative results from one experiment in a series with similar
results. Values shown are the Mean + SD absorbance at 450nm for triplicate samples. *
Indicates a significant difference between control (DMSO) and treated samples (p <.05).
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10

DISCUSSION

PAHs are environmentally prevalent compounds that are likely human
carcinogens. Major sources o f PAH exposure are char-broiled foods, cigarette smoke and
urban air (El-Bayoumy, 1992). PAHs are complete carcinogens in that they are capable
o f both tumor imitation and tumor promotion/progression (Pitot & Dragan, 1996). The
mechanism by which PAHs, such as BaP and DMBA, produce tumor initiation has been
extensively studied for the past three decades (Heidelberger, 1975). Metabolic activation
of PAHs by P450 enzymes appears to be critical in the formation of reactive diolepoxides that covalently bind to DNA and cause genotoxicity associated with
mutagenicity (Dipple, 1994). PAHs are biochemically activated by HMEC and DNA
|
i
|

adduct formation by PAHs has been well documented (Bartley et al., 1982; Leadon et al.,
1988; Stampfer et al., 1981). Interestingly, BaP has been found to be more mutagenic

i
I

than DMBA, which has been attributed to increased formation of the BaP 7,8-diol-9,10-

;

epoxide (BPDE) in HMEC (Gould et al., 1986).

f

In recent years, it has become clear that many carcinogens produce tumor

I

promotion and progression through non-genotoxic mechanisms, perhaps by modulating

i
;

growth factor signaling pathways in cells (Aaronson, 1991). Previous work in our

(

laboratories has shown that PAHs mobilize intracellular Ca2+ in lymphoid cells, and

t
i

perhaps trigger Ca2+-dependent pathways of cell activation (Burchiel et al., 1991). PAHs
do not alter Ca2+-independent signaling pathways, such as interleukin-4-induced B cell
mitogenesis (Davis & Burchiel, 1992). It is known that growth of HMEC is controlled in
part by several growth factor receptors that are associated with Ca2+ signaling pathways,
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including the epidermal growth factor receptor (Carpenter & Cohen, 1990) and insulin
like growth factor I (IGF-I) receptor (Ullrich & Schlessinger, 1990). Thus, it was of
interest to us to determine whether PAHs mobilize Ca2' in HMEC, in a manner analogous
to what we have observed in human lymphoid cells.
In human lymphocytes and lymphoid cell lines, we have identified two patterns of
Ca2' elevation produced by PAHs (Archuleta et al., 1993; Carpenter & Cohen, 1990;
Krieger et al., 1995). The first pattern is a relatively PAH-nonspecific activation of
protein tyrosine kinases (as indicated by sensitivity to genistein inhibition) that results in
a rapid, but transient increase in free intracellular Ca2'(Krieger et al., 1994). Previous
studies have shown that src family protein tyrosine kinases are rapidly activated by
PAHs, that Ca2* release is DVdependent, and that Ca2* is mobilized from intracellular
storage pools (Archuleta et al., 1993). The second pattern is a sustained increase in
intracellular Ca2* that lasts for 18 h or longer, and is less sensitive to inhibition by
genistein (Krieger et al., 1995). Sustained Ca2' elevation produced by PAHs in
lymphocytes has been shown to induce apoptosis (Burchiel et al., 1993). While the
mechanism by which PAHs produce sustained Ca2* elevation in lymphocytes is still
under investigation, two recent observations are noteworthy. First, immunotoxic and
carcinogenic PAHs, or associated metabolites, have been found to inhibit
sarcoplasmic/endoplasmic reticulum Ca2*-ATPases (SERCA), enzymes present in the
endoplasmic reticulum of lymphoid cells that function as Ca2* reuptake pumps following
Ca2* mobilization (Krieger et al., 1995). Thapsigargin is an atypical tumor promoter
which also acts by inhibition of SERCA activity (Thastrup et al., 1990). Second,
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inhibition of PAH metabolism by a-naphthoflavone (ANF), a P450 inhibitor and Ah
receptor partial antagonist, has been shown to reduce the sustained (18 h) Ca2+ response
of human lymphoid cells (Romero et a l 1997).
In the present studies the carcinogenic PAHs including BaP, DMBA, and TCDD
were found to produce statistically significant increases in intracellular Ca2+ in HMEC.
By contrast, the two weak or noncarcinogenic PAHs, BeP and anthracene, did not
produce a significant increase in Ca2+. There were differences in the patterns of Ca2+
elevation produced by BaP, DMBA, and TCDD in HMEC. DMBA and TCDD were
found to produce a more rapid and transient elevation of intracellular Ca2+peaking after
approximately 2 h of exposure, while BaP produced a more sustained increase in
intracellular Ca2+, lasting for 18 h or longer. The increase in intracellular Ca2+produced
by BaP at 18 h was nearly completely eliminated by co-incubating cells with an
equimolar concentration (10 pM) of ANF. At this concentration, ANF also produced a
small increase in intracellular Ca2+ in HMEC. Interestingly, ANF did not inhibit the 18 h
Ca2+-elevating response of HMEC to DMBA and TCDD. Since, ANF, DMBA, BaP, and
TCDD all produced an increase in intracellular Ca2+ in HMEC, an attractive hypothesis is
that the Ah receptor may play some role in Ca2+signaling. However, further studies are
necessary to resolve this point.
A second observation made in these studies was that BaP produces a more
sustained increase in intracellular Ca2+ in HMEC. The sustained Ca2+effect measured at
18 h was susceptible to inhibition by ANF, suggesting that metabolism may play a role in
the late Ca2+ elevation phase. BaP metabolism in HMEC has been previously examined
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by other investigators, and the formation of DNA-BPDE adducts in HMEC as early as 6
h after exposure to BaP has been reported (Gould et al., 1986; Leadon et al., 1988).
Further studies using BaP metabolites 7,8-dihydrodiol and 7,8-diol-9,10-epoxide to
induce changes in calcium homeostasis will help clarify the role of BaP metabolites, as
presented in Chapter II. Thus, there may be more than one mechanism by which PAHs
produce an increase in intracellular Ca2+ in HMEC, a finding that is consistent with our
previous results in lymphocytes (Krieger et al., 1995).
The sustained alterations in Ca2+induced by BaP treatment was shown to be of
biological significance, as determined by the ability of the compound to increase cell
proliferation of HMEC cultures both in the presence and absence of EGF. The greatest
mitogenic effects of BaP appeared to occur in the presence of EGF. The effects of BaP
I

on cell proliferation were most pronounced on day 4 in the presence of 1 and 5 ng/ml

I
I

EGF, suggesting that BaP may interact or synergize with other growth promoting
pathways. The fact that maximal proliferative effects of BaP were observed in 4 day

j;

cultures suggested that the sustained BaP-induced Ca2+elevation previously discussed

i

was not overtly cytotoxic to HMEC cultures. Cell viability was not affected by the

,

addition of BaP to HMEC cultures. Current studies are aimed at examining whether BaP

|

induces apoptosis in HMEC, as has been previously reported in murine B cells (Burchiel

|

et al., 1993).
It is unclear at this time what might be the significance of the transient Ca2+
effects produced by TCDD and/or DMBA. Previous studies have demonstrated that
TCDD alters EGFR expression in trout hepatocytes (Sewall et al., 1993). In addition,
TCDD has been demonstrated to be anti-mitogenic in certain human breast cancer cell
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lines (Fernandez & Safe, 1991; Gierthy et al., 1993; Liu et al., 1992). Additional studies
will be necessary to more fully characterize the effects of DMBA and TCDD on signaling
pathways associated with cell proliferation in HMEC.
In summary, BaP, DMBA, and TCDD were found to increase intracellular Ca2+
in normal HMEC following in vitro exposures. There were different temporal patterns of
Ca2+elevation observed. Preliminary data suggests that metabolism may be important in
the sustained Ca2+ response to BaP. A potential biologic significance o f BaP-induced
Ca2+ signaling may relate to the ability of this agent to mimic EGFR signaling and
mitogenesis. In support of this hypothesis, BaP was found to produce a significant
increase in the amount of cell proliferation measured in 4 d HMEC cultures in the
absence or presence of EGF. We hypothesize that PAH-induced alterations in
i

i

intracellular Ca2+ may play a role in signaling associated with human breast cancer

•

promotion and progression.

3
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CHAPTER II

Polycyclic Aromatic Hydrocarbon-Induced Alterations in Cell Growth: Potential
Correlation with Increased Intracellular Ca2+ and Tyrosine Phosphorylation in the
MCF-10A Human Mammary Epithelial Cell Line

BACKGROUND AND SIGNIFICANCE

Polycyclic aromatic hydrocarbons (PAHs) are environmentally prevalent
complete carcinogens capable of tumor initiation, promotion, and progression (Pitot &
Dragan, 1996). Some PAHs have been shown to induce mammary tumors in rodents
(Ethier & Ullrich, 1982). P450 metabolism of these compounds, particularly BaP,
produces potent carcinogenic metabolites in mammary tissue (Bartley et al., 1982),
including BaP-7,8-diol-9,10-epoxide (BPDE), which is thought to be the ultimate
genotoxic form of BaP (Conney, 1982; Cooper et al., 1983; Thakker et al., 1985). In
human mammary epithelial cells, the naturally occurring BaP is more mutagenic than the
synthetic DMBA, which is in contrast to observations in the rat mammary epithelial cell
system (Gould et al., 1986).
Studies investigating the mechanism of action of 7,12-dimethylbenz(a)anthracene
(DMBA) in relation to it’s immunosuppressive properties, have shown in the HPB-ALL
human T cell line, that exposure results in PLC-y activation, increased IP3formation,
membrane protein tyrosine phosphorylation, Src family kinase phosphorylation and
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activation, and rapid increases in intracellular Ca2+(Archuleta et al., 1993). PAH
activation of protein tyrosine kinases in human B cells has also been recently reported
(B.Mounho and S.Burchiel, in preparation). Our lab has also shown that PAHs are
capable of inhibiting Ca2+reuptake pumps present in the endoplasmic reticulum of
lymphocytes, which may be another mechanism by which PAHs produce sustained
elevation of intracellular Ca2+ (Krieger et al., 1995).
Ligand receptor-activated signaling pathways, such as EGFR, can activate
phospholipase Cy (PLC-y), which cleaves phosphoinositol bisphosphate (PIP2) into the
second messengers inositol trisphosphate (IP3) and diacyl glycerol (DAG) (Carpenter &
Cohen, 1990). IP3can bind to receptors on the ER and cause release of intracellular Ca2+,
which along with DAG, can then activate protein kinase C (PKC) and downstream
signaling pathways. Classic tumor promoters, such as phorbol esters, activate PKC in a
prolonged manner (Rasmussen et al., 1995). Non-classic tumor promoters like
thapsigargin inactivate calcium ATPases on the ER, resulting in elevated intracellular
Ca2+ (Thastrup et al., 1990). A common link between the action of these tumor
promoters is the involvement of Ca2+ as a second messenger.
Since the immunosuppressive and carcinogenic properties of PAHs are correlated,
it was of interest to determine if activation of the signaling components which participate
in downstream signaling can be activated in relation to growth factor signaling pathways
in human mammary epithelial cells. Previous studies by this laboratory have shown that
the potent carcinogen, BaP, produced sustained elevation of intracellular Ca2+ in primary
human mammary epithelial cells (HMEC), while two non-carcinogenic PAHs, BeP and

56

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

anthracene, did not induce such alterations (Chapter I, Figures 4 and 5). Comparison of
PAH effects on intracellular signaling between HMEC and MCF-10A could provide
important information on the usefulness of MCF-10A as a model for studying chemical
carcinogenesis. Therefore, in these studies we investigated the effects of PAHs and one
HAH on changes in intracellular Ca2+, the potential role of P450 metabolism in PAH
signaling, the growth effects of PAHs under growth factor-dependent conditions, and
finally the influence of PAHs on tyrosine phosphorylation status in whole cell lysate
preparations.

i

i
>
i
*

£
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MATERIALS AND METHODS

Chemicals and Reagents. All chemicals or reagents used were from Sigma
Chemical Co. (St. Louis, MO), unless otherwise indicated. The PAHs used in this study
included: benzo(a)pyrene (BaP), benzo(a)pyrene (BeP), 7,12-dimethylbenz(a)anthracene
(DMBA), anthracene (ANT), 3-methylcholanthracene (3-MC), dibenz(a,h)anthracene
(DAH), dibenz(a,c)anthracene (DAC), benz(a)anthracene (BA) with >95% purity as
assessed by the manufacturer. These chemicals were prepared weekly as stock solutions
in anhydrous tissue culture grade dimethyl sulphoxide (DMSO) and protected from light.
BaP metabolites 7,8-dihydrodiol and 7,8-diol-9,10-epoxide were purchased from
Midwest Research Institute (Kansas City, MO) and prepared every two weeks in DMSO,
protected from light and kept under nitrogen gas in the freezer. The final culture
concentration of the DMSO in all experiments was 0.2% or less. 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) was purchased from Cambridge Isotopes Labs
(Andover, MA) at >99% purity.
Culturing of MCF-10A. Medium consisted of Ham’s F-12 (JRH Biosciences,
Lenexa, KS) supplemented with 1 mg/ml bovine serum albumin (JRH Biosciences), 1
pg/ml hydrocortisone, 10 ng/ml EGF, 5 pg/ml insulin, 5 pg/ml gentamycin (Gibco BRL,
Grand Island, NY), 5 pg/ml transferrin, 50 pM sodium selenite, 10 pM 3,3’,5-triiodo-Lthyronine, 5 mM ethanolamine, 10 mM Hepes (Gibco BRL), 0.5 pg/ml fungizone (Gibco
BRL). Cells were grown on Vitrogen (Collagen Corporation, Palo Alto, CA) coated 100
mm2 dishes in a 10% C 02 incubator and were passaged every 4-5 days. For growth and
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T

Ca2+experiments, cells were cultured on Vitrogen coated 6-well plates (Coming Glass
Works, Coming, NY) and grown to subconfluence before being used (approx. 3 x 10s
cells per sample). Cells were a gift from Dr. Stephen P. Ethier.
Analysis of Intracellular Free Ca2+by Flow Cytometry. Samples were prepared
as previously described in Chapter I.
Assay for Mitogenic Activity. MCF-10A cells were plated in Vitrogen coated 6well plates (Coming Glass Works) at 3.5 x 104 cells/well, in one of three growth factor
defined conditions: serum-free complete media containing insulin (I), hydrocortisone (H),
and epidermal growth factor (E) - IHE, epidermal growth factor-deficient media (IH), or
insulin-deficient media (HE) with the addition of 5% FBS to allow attachment. The next
day, plating media was removed and cells were then treated with compound in one of the
*t

|

three growth factor defined conditions, at which time plating efficiency was also

5

•

performed to determine the number of attached cells/well. Cells were grown in
treatments for 6 days, with two media changes, and the number of cells were then

*

determined by counting of isolated nuclei with a Coulter Counter (Ethier et al., 1987).
Anti-phosphotyrosine Western Blots. Cells were plated at 1 x 105cells per

:

plate into 100 mm culture dishes (Coming Glass Works) and cultured until subconfluent.
Cells were then placed in serum free media containing hydrocortisone (SFH) for 8-24 h,

f

and were then treated overnight (18 h) with compound. One 100 mm dish was used per
sample. For herbimycin A experiments, herbimycin A (Calbiochem, La Jolla, CA) was
reconstituted in DMSO to a solution of 1.75 mM, then diluted with phosphate buffered
saline (PBS, Gibco, BRL) to a 0.04 mM stock solution. Cells were cultured in 150 mm
dishes (Coming Glass Works) until subconfluent. Cells were then pretreated with
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herbimycin A (or DMSO as control) for 8 h in SFH, and then compound +/- herbimycin
A was added for 18 h. Loss of cell viability due to 26 h of herbimycin A exposure
resulted in lower protein recovery from these samples, but was corrected for by protein
normalization. Cells were rinsed twice with ice cold Hank’s BSS (Gibco BRL) and then
lysed on ice with a buffer consisting of 50 mM Tris-HCl, pH 7.5,150 mM NaCl, 1%
Nonidet P-40,0.25% sodium deoxycholate, 10 pg/ml bovine serum albumin and
supplemented with 30 mM sodium pyrophosphate, 150 mM sodium orthovanadate, 300
pg/ml phenylmethysulfonyl fluoride, 20 pg/ml aprotinin, and 10 pg/ml leupeptin, as
previously described (Woods Ignatoski & Verderame, 1996). Lysates were spun at
16,000 x g at 4°C for 10 mins. and then analyzed for protein using a modified Lowry’s
method. Proteins from the whole cell lysates were separated on 7.5% polyacrylamide gel
f
i

containing SDS, transferred to PVDF and probed with the anti-phosphotyrosine antibody
4G10 (Upstate Biotechnology Incorporated, Lake Placid, NY).

;
i

Statistical Design and Analysis. Data were analyzed for statistical differences
(p<0.05) between control and treated groups using SigmaStat statistical software (Jandel
Scientific, San Rafael, CA). ANOVA followed by Dunnett’s t-tests were performed on

s

sample means.
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RESULTS

Evaluation of Changes in Intracellular Ca2+ Produced by Carcinogenic and
Noncarcinogenic PAHs. A series of eight compounds varying in carcinogenicity were
analyzed for their ability to elevate intracellular Ca2+ by flow cytometric analysis.
MCF10A cells were treated overnight (18 h) with one of eight different PAHs at 3 pM to
determine if carcinogenic and noncarcinogenic compounds differed in their ability to alter
intracellular Ca2+, as previously seen in primary cultures of mammary epithelial cells
(Chapter I). The pooled results of three separate experiments are shown in Figure 9.
Three potent carcinogenic PAHs, benzo(a)pyrene (BaP), dimethylbenzanthracene
(DMBA), and 3-methylcholanthracene (3-MC), all caused significant increases, greater
i

’
I

than a 100 channel shift, in intracellular Ca2+. The weak or noncarcinogenic PAHs,
including dibenz(a,c)anthracene (DAC), dibenz(a,h)-anthracene (DAH),

i

:
f
l

benz(a)anthracene (BA), anthracene (Anth) produced small, but statistically significant
increases in intracellular Ca2+ in MCF-10A. Benzo(e)pyrene did not increase intracellular

i
Ca2+ in MCF-10A at 18 h. The significant increases in intracellular Ca2+ induced by BaP
■

and DMBA, and the slight alterations induced by BeP or anthracene, are in general
agreement with the effects seen at the 3 pM concentration between carcinogenic and
weakly carcinogenic compounds reported previously in HMEC (Chapter I, Figure 4 and
5).
Carcinogenic PAHs Produce Dose-Dependent Increases in Intracellular Ca2+
in MCF-10A. The three most potent compounds, BaP, DMBA, and 3-MC, were
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Figure 9. Structure activity relationships of PAHs for alterations in intracellular Ca2+.
MCF-10A cells were incubated overnight (18 h) in culture with 3pM PAH and were then
analyzed by flow cytometry for intracellular Ca2+, as measured by changes in the
fluorescence ratio of two Ca2+ chelating dyes, 4-p.M Fluo-3 AM and 9pM Fura Red AM.
Data is expressed as the change in mean channel fluorescence ratio compared to DMSO
(0.1%, solvent control) treated samples and are the Mean ± SE for three separate
experiments, using quadruplicate samples in each experiment. The actual mean channel
number for DMSO-treated samples was channel 253 ± 1 1 . * indicates a significant (p <
.05) increase in Ca2+compared to DMSO controls.
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Figure 10. Dose response for sustained elevation of intracellular Ca2+ in MCF-10A.
MCF-10A cells were incubated overnight (18 h) in culture with 0.03 0.3, or 3 pM PAHs,
and were then analyzed by flow cytometry for intracellular Ca2+as described in Figure 4.
Data shown is the Mean ± SE for two separate experiments, with quadruplicate samples
in both experiments. The actual mean channel number for the DMSO control group was
272 + 10. * indicates a significant (p < .05) increase in Ca2+ compared to DMSO
controls.

63a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

400 -

BaP

350 -

DMBA
3M C

Calcium

Channel Shift

300 2 50 -

200

-

150 -

100

-

50 -

.03

3
jjM PAH

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3

evaluated for their dose-response relationships for Ca2+ elevation in MCF-10A. Cells
were treated for 18 h at 0.03, 0.3, or 3 pM, and were then analyzed for changes in
intracellular Ca2+by flow cytometry. Results were similar to those seen in Figure 9, with
all three compounds producing statistically significant increases in Ca2+ at 3 pM (Figure
10). BaP produced a much larger increase in intracellular Ca2+than did DMBA or 3-MC,
and BaP was the only compound to produce a significant effect at 0.3 pM. None of the
PAHs increased Ca2+at a concentration of 0.03 pM.
Kinetics of Ca2+ Elevation in MCF-10A. We have found previously in HMEC
that maximal Ca2+elevation produced by BaP may require 18 h, whereas some PAHs,
such as DMBA and TCDD, may act more quickly (Chapter I, Figure 6). Therefore, it was
of interest to compare the time-dependence for Ca2+elevation by carcinogenic PAHs,
including BaP, DMBA, 3-MC, TCDD, and BaP-7,8-dihydrodiol in MCF-10A cells
(Figure 11). BaP-7,8-dihydrodiol was included because preliminary data suggested that
this P450-derived metabolite may be important in Ca2+elevation produced by BaP. We
found that BaP, DMBA, and BaP-7,8-dihydrodiol all produced significant increases in
intracellular Ca2+ in MCF-10A following 6 or 18 h of exposure. BaP and BaP-7,8dihydrodiol both produced sustained alterations in intracellular Ca2+ for up to 72 h (data
not shown). A similar result was found with BaP treatment of HMEC (Chapter I, Figure
6). None of the PAHs produced a statistically significant increase in Ca2+at 2 h. TCDD
did not increase intracellular Ca2+at any time point, whereas 3-MC appeared to produce a
trend toward an increase with time, but none of the values proved to be statistically
different from controls in this experiment. Interestingly, the BaP-7,8-dihydrodiol was
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Figure 11. Time course for alterations in intracellular Ca2+ in MCF-10A. Cells were
incubated in culture with PAH or HAH, with the last two hours of exposure completed
suspension in the presence of 4 pM Fluo-3 AM and 9 pM Fura Red AM. Results are
<

I

Mean ± SE for two experiments, with quadruplicate samples in each experiment. The

[

mean channel number for DMSO vehicle-treated cultures was 362 + 18. * indicates a

i

i
;

significant increase in Ca as compared to DMSO solvent control (p < 0.05).

3
f,
V
\
\I

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

350 -

2 hours
6 hours
18 hours

300 -

|

250

co

“o5

|.c(0

200

1

150

0

CO

O

100 -I

50 -

0

It
a

j

A

%

65b

»
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 12. ANF-induced alterations of the sustained elevation of intracellular Ca2+ in
MCF-10A. Cells were treated with 3 jiM BaP or BaP-7,8-dihydrodiol + ANF in cultures
for 18 h. Results shown represent the change in Ca2+channel number, as described in
Figure 1. Results are from a representative experiment analyzing quadruplicate samples.
f
The mean channel number for DMSO control samples was 299 + 7, and for the ANF
I

treatment group was 284 ±8. * indicates a significant difference between control
(DMSO or ANF) and treated samples, + indicates a significant difference between ANF
treated samples and non-ANF treated samples (p< 0.05).
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much more effective than BaP in increasing intracellular Ca2+ in MCF-10A, suggesting
that P450 metabolism may play a role in Ca2+ elevation by this PAH.
a-Naphthoflavone reduces the Ca2+ elevation induced by BaP and BaP-7,8
dihydrodiol. a-naphthoflavone (ANF) is an inhibitor of the P450 1A and IB enzymes
that are responsible for the conversion of BaP to BaP-7,8-dihyrdodiol (in presence of
epoxide hydrolase) and ultimately to BaP-7,8 diol-9,10 epoxide (BPDE) in several cells
and tissues, including HMEC (Stampfer et al., 1981). BPDE is considered the ultimate
carcinogenic metabolite of the parent compound BaP (Conney, 1982; Cooper et al., 1983;
Thakker et al., 1985). Therefore, it was of interest to determine whether ANF could alter
the Ca2+response produced by BaP and BaP-7,8-dihyrdodiol in MCF-10A cells. An
equimolar (3 pM) concentration of ANF was found to reduce the Ca2+-elevating effects of
BaP and BaP-7,8-dihyrdodiol during an 18 h exposure period (Figure 12). ANF
decreased the Ca2+-elevating response of BaP by nearly 50%, but was less effective for
the BaP-7,8-dihyrdodiol (~33% decrease). We also directly examined the effects of
BPDE in these experiments, but it proved to be too toxic to cells at equimolar
concentrations to permit accurate analysis of Ca2+ in viable cells. Overall, these results
are consistent with the hypothesis that P450-derived BaP metabolites may contribute to
the late and sustained Ca2+-elevating effects seen in MCF-10A.
PAHs modulate cell growth in the MCF-10A cell line. We have shown
previously that under some conditions PAHs exert mitogenic effects, or can replace
certain growth factors, in primary cultures o f HMEC supplemented with insulin (I),
epidermal growth factor (E), hydrocortisone (H) and serum (Chapter I, Figure 8). In the
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Figure 13. TCDD- and BaP-induced alterations in MCF-10A proliferation under growth
factor defined conditions. MCF-10A cells were initially plated in one of three growth
factor defined conditions: serum-free complete media containing insulin (I),
hydrocortisone (H), and epidermal growth factor (E) - IHE, epidermal growth factordeficient media (IH), or insulin-deficient media (HE). The plating efficiency was
I

determined by counting cell nuclei 24 h after plating cells, at which time cells were

J

treated with PAH or HAH. Cell growth was assessed 6 days after treatment by counting

t

isolated nuclei, as described in Methods. Results shown are the Mean + SE for cell counts
obtained from triplicate cultures for a representative experiment repeated on at least three
occasions. Percents shown are of DMSO control for that growth factor condition.
* indicates a significant difference compared to DMSO control (p< 0.05).
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present studies, a serum-free media developed by Ethier et al. (Ethier & Moorthy, 1991;
Ethier et al., 1991) supplemented with I, H, E was utilized to determine whether PAHs
alter cell growth of MCF-10A cells under growth factor-dependent conditions. MCF-10A
cells grown in complete media (IHE media) were found to have decreased cell growth
after 6 days of treatment in the presence of BaP (.03-3 pM), whereas TCDD (30 nM) had
no effect on cell growth in IHE media (Figure 13). The removal of E from the media (IH
media) resulted in a major decrease in cell proliferation, with 0.3 pM BaP exerting a
small decrease in cell growth and 30 nM TCDD producing a small increase in the number
of recovered cells. In insulin-deficient media (HE media), BaP (.03 pM) produced a
small increase in MCF-10A cell growth (21% increase above control). However, TCDD
produced nearly a doubling in the number o f recovered cells in HE media (66% increase
above control). The results of several experiments suggest that PAHs, such as BaP and
TCDD may have mild insulin-like signaling properties in MCF-10A cells.
BaP and TCDD increase tyrosine phosphorylation in MCF-10A. Since
activation of the EGFR signaling pathway is important for inducing cell proliferation in
MCF-10A, activation o f which can lead to mobilization of intracellular Ca2+through
PLC-y, the ability o f BaP to activate growth factor signaling pathways by protein
tyrosine kinases was investigated using anti-phosphotyrosine Western blots (Figure 14).
Cultures of MCF-10A were treated with 0.3 pM BaP for 18 h under three different
growth factor-defined conditions in IHE, IH, and HE media. BaP was found to cause a
significant increase in tyrosine phosphorylation of high molecular weight proteins in the
regions of 60-70 kD, 110-125 kD and 160-190 kD in HE media. These proteins were also
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Figure 14. BaP-induced alterations in tyrosine phosphorylation of MCF-1OA whole cell
lysates under growth factor defined conditions. MCF-10A cells were placed in growth
factor-deprived media for 24 h and were then treated for 18 h with .3 pM BaP in IHE, IH
or IH media, as defined in Figure 10. 75 pg of protein were resolved on a 10% gel,
<
<
I
i
f

transferred to a PVDF membrane, and probed with an anti-phosphotyrosine antibody
(4G10). Results shown are from a representative experiment conducted at least three

£

times.
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Figure 15. TCDD- and BaP-induced tyrosine phosphorylation of MCF-10A whole cell
lysates under insulin-deficient conditions. Cells were in growth factor-deprived media for
8 h, then treated overnight in insulin-deficient media (HE) with 30nM TCDD, 3.0 pM
BaP or 0.3 pM BaP. 100 pg of whole cell lysates were resolved on a 7.5% gel,
transferred to PVDF membrane and probed with anti-phosphotyrosine antibody (4G10).
Results shown are from a representative experiment done at least four times.
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seen in complete media (where insulin was present), suggesting that BaP induces an
insulin-like signal in MCF-10A cells. There were no other noticeable changes in the level
of tyrosine phosphorylation under the other growth factor-defined conditions. A similar
experiment was performed in HE media with 30 nM TCDD (Figure 15). Results showed
that TCDD produced an increase in tyrosine phosphorylation of the 110-125 kD and 160190 kD bands in HE media (Figure 15, lane 4), in a manner similar to BaP under HE
conditions (Figure 15, lanes 2 and 3). Use of the noncarcinogenic PAH, BeP, under
identical conditions, did not show an increase in tyrosine phosphorylation of any proteins,
indicating that the effect of BaP and TCDD is specific (Figure 16). These results suggest
that BaP and TCDD may activate insulin-like signaling pathways, and are in general
agreement with the modest insulin-like growth effects of BaP and TCDD seen in MCF10A reported above (Figure 13).
Herbimycin A inhibits tyrosine phosphorylation induced by BaP and BaP7.8-dihydrodiol. In another experiment, similar to that shown in Figure 14, it was found
that BaP (0.3 pM) and BaP-7,8-dihydrodiol (0.3 pM) produced a profound increase in
tyrosine phosphorylation in MCF-10A cells exposed for 18 h in insulin-deficient HE
media (Figure 17). Anti-phosphotyrosine Western blots showed that both BaP and Bap7.8-dihydrodiol increased tyrosine phosphorylation o f proteins in the 60-70 kD, 110-125
kD and 160-190 kD size range (Figure 17, lanes 3 and 5), as compared to HE control
(Figure 17, lane 2). The general protein tyrosine kinase inhibitor, herbimycin A, was
found to selectively inhibit tyrosine phosphorylation of the 160-190 kD protein bands
induced by BaP and BaP-7,8-dihydrodiol, with only a slight reduction in the

72

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

phosphorylation of the 60-70 kD and 110-125 kD bands (Figure 17, lanes 4 and 6). Of
note, herbimycin A and other protein kinase inhibitors that we have studied, all
significantly inhibited the growth of MCF-10A cells. Therefore, reduced protein
recovery was adjusted for by protein normalization. For unknown reasons, strong BaPinduced tyrosine phosphorylation of the 60-70 kD bands was not seen in all experiments
(see Figures 14 and 15). The various identities of the protein bands that demonstrated
increased tyrosine phosphorylation in these studies is currently under investigation.
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Figure 16. Anti-phosphotyrosine blot of BeP treated MCF-10A whole cell lysates under
insulin-deficient conditions. MCF-10A were placed in growth factor deprived conditions
for 8 h, and then treated for 18 h with 0.3 pM BeP. 125 pg o f whole cell lysates were
resolved on a 7.5% gel, transferred to PVDF, and probed with anti-phosphotyrosine
antibody (4G10). Each lane represents a replicate sample, from separate plates.
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Figure 17. Herbimycin A inhibition of tyrosine phosphorylation of BaP- and BaP-7,8dihydrodiol treated MCF-10A whole cell lysates. Cells were placed in growth factordeprived media +/- 400nM herbimycin A for 9 h, then treated in insulin deficient media
(HE) with 0.3 pM BaP or BaP-7,8-dihydrodiol +/- 400nM herbimycin A for 18 h. A
sample without growth factors was also treated with DMSO for 18 h (H). 125 jig of
whole cell lysates were resolved on a 7.5% gel, transferred to a PVDF membrane, and
probed with an anti-phosphotyrosine antibody (4G10). Results shown are from a
representative experiment conducted three times.
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DISCUSSION

In the present studies, a series of carcinogenic and noncarcinogenic compounds
were analyzed for their ability to elevate intracellular Ca2+ in the MCF-10A human
mammary cell line, influence tyrosine phosphorylation, and alter growth factor-dependent
cell growth. The MCF-10A cell line was chosen because it can be grown under serumfree and growth factor-defined conditions in tissue culture, and because it appears to
resemble normal human mammary epithelial cells (HMEC) in growth characteristics
(Soule et al., 1990). We have recently shown that carcinogenic PAHs and TCDD
increase intracellular Ca2+ and may have weak mitogenic effects in primary HMEC
cultures (Chapter I, Figure 8). However, we noted some heterogeneity in the responses of
isolated HMEC to PAHs. Therefore, use of a cloned human cell line would have
advantages in performing various cell growth and biochemical assays.
Carcinogenic PAHs, including BaP, DMBA and 3-MC were found to produce
statistically significant increases in intracellular Ca2+ in MCF-10A following 6 and 18 h
o f exposure. By contrast, noncarcinogenic, or weakly carcinogenic PAHs (Wislocki &
Lu, 1988), such as DAH, DAC, BA, BeP, and Anth produced little, if any, increase in
intracellular Ca2+ in MCF-10A. The carcinogenicity of many PAHs has been assessed in
rodent systems, where hepatic metabolism of the compounds to proximate and ultimate
carcinogens is likely to contribute to the assessment of the carcinogenicity (Conney,
1982; White, 1986). In vitro human culture systems are likely to produce different
results concerning the potency of PAHs as carcinogenic and immunosuppressive
compounds, as was demonstrated by Davila et al. (1996) who evaluated the structure
76
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activity relationships of PAHs with respect to effects on human T cell mitogenesis. DAH
and BA are considered moderate carcinogens in rodent systems, more so than DAC
(White, 1986), but when assessed as inhibitors of human T cell mitogenesis, all three
were weakly inhibitory (Davila et al., 1996). The weakly immunosuppressive properties
of these three compounds correlates with our observation that these compounds produced
only slight alterations in intracellular Ca2+ in MCF-10A cells, similar to the weakly
carcinogenic compounds BeP and Anth (Figure 9). Therefore, the immunotoxicity and
carcinogenicity PAHs in human systems seems to correlate, but this is likely to differ
from in vivo rodent-derived assessments.
While the mechanism of Ca2+elevation by PAHs was not specifically addressed in
the present studies, we have previously shown in human lymphocytes that PAHs, such as
BaP, may require metabolism to active species to exert immunotoxic or sustained Ca2+*

elevating effects (Davila et al., 1996; Mounho & Burchiel, 1997). Therefore, it was

-.

interesting to note that an important P450 and epoxide hydrolase metabolite of BaP,
BaP-7,8-dihydrodiol, was more effective than BaP in elevating intracellular Ca2+ in MCF10A. We have not yet directly examined the metabolism of BaP by MCF-10A, but breast
epithelial cells are known to have the necessary P450s, such as P4501 A l, to metabolize

i
PAHs (Bartley et al., 1982; Gould et al., 1986; Leadon et al., 1988; Stampfer et al.,
t

1981). Recently it has been shown that rat mammary stromal fibroblasts also metabolize
PAHs, principally via the P450 1B1 enzyme, to reactive metabolites (Christou et al.,
1995). The theory that P450 metabolism is associated with Ca2+elevation by PAHs is
further supported by the finding in these studies that ANF, an inhibitor of P4501A and IB
metabolism and a partial Ah receptor antagonist (Merchant et al., 1990; Merchant et al.,
11
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1992), was able to significantly diminish the Ca2+-elevating effects of both BaP and Bap7,8-dihydrodiol. These results are similar to those previously reported (B.Mounho and
S.Burchiel, in preparation) in the Daudi human B cell line, where BPDE was also found
to be a potent inducer of Ca2+ elevation. Interestingly, BaP-7,8-dihydrodiol did not affect
Ca2+ homeostasis until 6 h after treatment suggesting that metabolism to BaP-7,8-diol9,10-epoxide may be necessary for the Ca2+-elevating effect, although treatment with
ANF suggests that this only partially contritbutes to the effects of BaP-7,8-dihydrodiol
(see Figure 12). Other P450-drived metabolites, not inhibited by CYP 1A and IB
inhibitor ANF, may also contribute to the effects seen. Since none of the compounds
tested produced significant alterations in Ca2+after a 2 h treatment (Figure 11), it is more
likely that the delayed effect of BaP-7,8-dihydrdiol is due to slow propagation of the
f
;
i
l

signals required to create an increase in intracellular Ca2+. As will be discussed in
Chapter III, even tyrosine phosphorylation of signaling molecules occurs in a delayed

'*

;

manner compared to other cell signaling systesm, such as lymphocytes, and in

1:

comparison to normal signal transduction induced by ligand binding to membrane

:

receptors. The role of BPDE in Ca2+ elevation in MCF-10A is somewhat uncertain, due
to the fact that this compound proved to be too toxic to cells to permit direct analysis of

S

j

effects on intracellular Ca2+ when used at equimolar concentrations.
We found that TCDD was not able to produce significant Ca2+elevation in MCF10A cells at time points ranging from 2-18 h. These results differ from those obtained in
HMEC, where TCDD produced a statistically significant, albeit transient increase in Ca2+
2 h after exposure (Chapter I, Figure 6). The reason for this difference is unclear at the
present time. However, we are in the process of characterizing Ah receptor, ARNT, and
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P450 expression in MCF-10A to see if this cell line possesses functionally active
receptors.
Although TCDD is a tumor promoter, studies have shown that TCDD treatment
can decrease EGFR levels (Sewall et al., 1995) and decrease EGFR binding affinity
(Hudson et al., 1985). TCDD has also been shown to decrease growth of the human
MCF-7 breast cancer cell line by increasing production of TGFp (Vogel & Abel, 1995).
TCDD also inhibits insulin-induced responses of MCF-7 (Liu & Safe, 1996). Therefore
it is noteworthy that in these studies both BaP and TCDD were able to influence growth
of MCF-10A cells under growth factor-defined conditions. BaP inhibited growth of
MCF-10A in complete defined media containing hydrocortisone (H), insulin (I), and
epidermal growth factor (E) - IHE. However, BaP had a weak mitogenic effect in
insulin-deficient (HE) media. TCDD had little or no effect on MCF-10A growth in
i

complete EHE media, but it produced nearly a doubling o f the number of cells in HE
media. Thus, both BaP and TCDD appeared to have insulin-like growth-promoting

$
>
;
*£
-

effects in MCF-10A in the absence of exogenous insulin. This observation may be
important, since agents which exert mitogenic effects on breast cells are also likely
candidate inducers of tumor promotion and progression (Aaronson, 1991; Foster, 1997).
The significance of the growth promoting effect of these compounds only in insulin-

[

deficient media is unclear at the present time. Circulating levels of IGF-I, which acts as a
strong mitogen through binding to insulin-like growth factor receptor-I, are sequestered
by IGF-binding proteins, leaving very low levels of free IGF-I (LeRoith, 1997). Of
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interest, IGF-1 levels decline in the third decade of life, parallel to changes in growth
hormone secretion, possibly leaving tissues susceptible to xenobiotics (LeRoith, 1992).
Since there was a lack of correlation between Ca2+elevation by TCDD and BaP, it
is difficult to conclude that PAHs and TCDD act by similar mechanisms in promoting
MCF-10A cell growth. Therefore, we investigated other potential signaling pathways
that may or may not correlate with changes in intracellular Ca2+. PAHs and TCDD have
previously been shown to increase tyrosine phosphorylation in numerous cells and tissues
(Archuleta et al., 1993; Matsumura, 1994; B.Mounho & S.Burchiel, in preparation).
Since growth factor receptors, particularly insulin and epidermal growth factor receptors,
utilize protein tyrosine kinases in signaling (Carpenter & Cohen, 1990; White & Kahn,
1994), it was o f interest to determine whether BaP and TCDD alter tyrosine
!

phosphorylation in MCF-10A cells. The results of these studies showed that BaP and
TCDD both increased tyrosine phosphorylation of 110-125 kD and 160-190 kD proteins
present in whole cell lysates prepared from MCF-10A cells grown in insulin-deficient HE
media, but not in complete IHE media. BaP-7,8-dihydrodiol also increased tyrosine
phosphorylation of these high molecular weight proteins. Herbimycin A, a general

?
\
\

tyrosine kinase inhibitor, was found to inhibit tyrosine phosphorylation o f the 160-190
kD proteins, but not smaller proteins (i.e., 60-70 kD range) detected in some Western

i

;

blots. The identities of these high molecular weight proteins is uncertain at this time.
However, potentially important candidate signaling proteins in the 110-125 kD and 160190 kD size range include PLC-y, IRS-1, and EGFR. Likely signaling molecules that

80
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may undergo changes in tyrosine phosphorylation in the 60-70 kD range include src and
She family proteins.
The mechanism by which PAHs increase tyrosine phosphorylation in MCF-10A
is currently under investigation. Interestingly, it has been shown that protein tyrosine
kinases may be activated by redox-active agents (Schieven et al., 1993), which could
include certain PAH metabolites. Other investigators have shown that oxidative agents,
such as pervanadate, increase insulin signaling in skeletal muscle cells (Tsiani et al.,
1997). Thus, further studies will be aimed at evaluating the redox status of MCF-10A
following exposure to carcinogenic PAHs.
In summary, carcinogenic PAHs, including BaP, DMBA, 3-MC and the BaP
metabolite 7,8-dihydrodiol were found to increase intracellular Ca2+ in the human
mammary epithelial cell line MCF-10A following in vitro exposures. The Ca2+-elevating
effects of BaP and BaP-7,8-dihydrodiol were partially sensitive to inhibition by ANF,
indicating that P450 metabolites or Ah receptors may contribute to Ca2+ elevation.
TCDD and BaP increased growth of MCF-10A cells in insulin-deficient (HE) media
demonstrating that these agents may exert insulin-mimetic effects under certain growth
conditions. The lack o f effects of TCDD on intracellular Ca2+ implicated other potential
signaling pathways in growth promotion. TCDD, BaP, and BaP-7,8-dihydrodiol were
found to increase tyrosine phosphorylation of several high molecular proteins in MCF10A cells grown in HE media, an effect which was sensitive to herbimycin A. Thus, these
results suggest that PAHs and TCDD activate protein tyrosine kinases that may be
associated with insulin signaling pathways in MCF-10A cells.

si
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CHAPTER HI

Polycyclic Aromatic Hydrocarbon- and Halogenated Aromatic HydrocarbonInduced Alterations in Insulin-Like Growth Factor Signaling Pathways in the MCF10A Human Mammary Epithelial Cell Line

BACKGROUND AND SIGNIFICANCE

Polycyclic aromatic hydrocarbons (PAHs) are a family of complete carcinogens
that are formed as by-products of combustion (Baum, 1978). Human exposure to PAHs
can occur through ingestion of contaminated food sources and smoked or char-broiled
Z

t

foods, inhalation of cigarette smoke or polluted air, or through occupational exposure
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(coke oven or iron foundry workers) (El-Bayoumy, 1992; Hattemer-Frey & Travis, 1991;
Hoffmann & Hecht, 1990; Lijinsky, 1991; Lijinsky & Shubik, 1964). Some PAHs have

\i!________________________________________________________________________
!
been shown to induce mammary tumors in rodents (Ethier, 1985). While the synthetic
PAH, 7,12-dimethylbenz(a)anthracene (DMBA), has traditionally been shown to be a
more potent carcinogen than the naturally occurring benzo(a)pyrene (BaP), studies in this
lab and others have shown that BaP may be a more immunosuppressive and carcinogenic
in human systems than DMBA (Davila et al., 1995; Davila et al., 1996; Gould et al.,
1986; Moore et al., 1987; Moore et al., 1986; Mounho & Burchiel, 1997). 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD), better known as dioxin, is a chemical carcinogen
that is a very potent tumor promoter, but has virtually no initiating activity (Lucier et al.,
1991; Pitot & Sirica, 1980; Poland & Knutson, 1982). Both BaP and TCDD bind with
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high affinity to a cytosolic receptor, the aryl hydrocarbon receptor (Ah receptor or AhR)
(Poland et al., 1976), which causes dissociation of two heat shock proteins (hsp90) with
subsequent translocation of the ligand bound AhR to the nucleus (Henry & Gasiewicz,
1993). In the nucleus, the liganded AhR associates with Ah receptor nuclear translocator
protein (ARNT), forming a heteromeric-DNA-binding complex (AhR-ARNT) (Pollenz et
al., 1994). This AhR-ARNT complex then binds to xenobiotic response elements (XREs)
in the promoter regions of responsive genes and induces the transcription of these genes
(Denison et al., 1988). The cytochrome P450s CYP1 Al/2, are two genes which undergo
transcriptional activation following AhR-ARNT complex binding (Thomas et al., 1983;
Tritscher et al., 1992; Whitlock et al., 1989). Polycyclic aromatic hydrocarbons and
some polychlorinated biphenyls, are able to bind the Ah receptor, resulting in
|

transcriptional activation of responsive genes, but they are not as potent as TCDD

!

(Goldstein & Safe, 1989; Kafafi et al., 1993). Previous studies have shown a good

i

correlation between the binding affinity of compounds to the AhR and their ability to

%
induce toxicity (Goldstein & Safe, 1989; Poland & Knutson, 1982; Safe, 1994).
Treatment of mouse hepatoma cells with TCDD and BaP has been shown to cause
an increase in mRNA levels of the immediate-early genes c-fos, c-jun, junB and junD and
an increase in AP-l-DNA binding activity, with induction o f c-fos and junB occurring
independently of AhR and ARNT (Puga et al., 1992). Other studies have shown that
TCDD is able to cause rapid increases in protein kinase activation in an AhR-dependent
fashion, but without transcriptional activation, leading to stimulation of MAPK and
protein tyrosine kinases in an equally rapid manner (Enan & Matsumura, 1995). TCDD
treatment can activate response elements other than XREs. TCDD treatment caused
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stimulation of expression plasmids containing XRE motifs, but serum response element
(SRE)-containing expression plasmids were stimulated equally well by TCDD whether or
not AhR and ARNT were coexpressed (Hoffer et al., 1996).
TCDD, and to some extent BaP, have recently been shown to increase the growth
o f MCF-10A under insulin-deficient conditions (Chapter II, Figure 13). This suggests
that these compounds may possess IGF-I-mimetic properties. Insulin and insulin-like
growth factors are peptide hormones that bind with high affinity to the insulin receptor
(IR) and insulin-like growth factor receptor-I (IGF-IR), respectively (Czech, 1989).
While insulin mediates metabolic functions (and growth at supraphysiological
concentration), in vivo it is the insulin-like growth factor-I (IGF-I) that is important for
growth during embryogenesis and postnatal development (Baker et al., 1993; Liu et al.,
1993). IGF-I is responsible for the control of proliferation of many types of cells, all of
which are mediated through the insulin-like growth factor receptor I (IGF-IR) (Baserga &
Rubin, 1993; Lowe, 1991). A critical event for initiation o f downstream signaling events
leading to mitogenesis is receptor p subunit transphosphorylation and subsequent tyrosine
phosphorylation of two important docking molecules - She (Pellici et al., 1992; Pronk et
al., 1993) and IRS-1 (Sun et al., 1991). IRS-1 has over 20 tyrosine phosphorylation sites,
which serve as docking sites for SH2 domain containing proteins such as Nek (Lee et al.,
1993), PTP2 (Sun et al., 1993), p85 subunit of PI3K (Backer et al., 1992), and Grb2-Sos
(Skolnik et al., 1993). She also binds Grb2-Sos, which then leads to ras-GDP nucleotide
exchange to ras-GTP (Skolnik et al., 1993). She is the predominant signaling molecule
linking insulin receptor and IGF-IR signaling to form ras-GTP formation (Sasaoka et al.,

84
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1994; Sasaoka et al., 1996). The She family of adapter proteins consists of p66, p52 and
p46, which associate with and can be activated by EGFR, IR and IGF-IR (Pellici et al.,
1992; Pronk et al., 1993; Pronk et al., 1994; Sasaoka et al., 1994).
The second main pathway leading to cell proliferation in the insulin signaling
pathway involves activation of PI3-kinase (PI3K). PI3K is a dimer that is composed of
an adapter protein (p85) and a catalytic subunit (pi 10). SH2 domain binding of p85 to
IRS-1 leads to PI3K activation mediated via the pi 10 catalytic subunit (Myers et al.,
1992). Substrates for PI3K are phosphatidylinositol (PI), and PI 4-P and PI 4,5-P2, all of
which become phosphorylated on the 3’ position of the inositol ring (Cantley et a l, 1991;
Whitman et al., 1988). Products of PI3K have been shown to be important mediators of
mitogenesis mediated by various growth factor receptors (Varticovski et al., 1994),
including PDGF (Hu et al., 1992; Severinsson et al., 1990), colony-stimulating factor 1
(Shurtleff et al., 1990), and insulin (Cheatham et al., 1994). EGFR lacks the YXXM
motif that is necessary for strong p85-phosphotyrosine association, and is likely not
biologically important in the activation of PI3K.
There are several lines of evidence that point to a role for IGF-IR and insulin- and
IGF-induced signaling in transformation, specifically leading to breast cancer. IGFs have
been shown to be potent mitogens for breast cancer cells in vitro (Osborne et al., 1990;
Osbome et al., 1989; Yee et al., 1988), with IGF-I being a more potent mitogen than
IGF-H (Osbome et al., 1990; Yee et al., 1988). These findings correlate with the binding
affinities of IGFs for IGF-IR. It is believed that IGF-I acts in a paracrine manner, being
synthesized by surrounding adipose tissue and stromal cells (Doglio et al., 1987; Yee et
al., 1989). IGF-II may act as both a paracrine and autocrine factor, since mRNA and
85
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protein can be detected in breast cancer cell lines, malignant breast epithelial cells and
stromal cells (Lee et al., 1994; Osbome et al., 1989; Paik, 1992; Quinn et al., 1996; Yee
et al., 1988). IR content and IGF-IR ligand binding is higher in malignant breast tissue
than in normal tissue (Jammes et al., 1992; Papa et al., 1990). In addition, 82-87% of
breast cancers have been shown to express IGF-IR (Papa et al., 1993; Peyrat et al., 1990)
and women with breast cancer have more circulating IGF-I than healthy age matched
controls (Peyrat et al., 1990).
Free levels of the mitogens IGF-I and IGF-II are tightly regulated in the
circulation by high affinity binding of insulin-like growth factor binding proteins
(IGFBPs), leaving low levels of the IGFs available for tissue interaction (Jones &
Clemmons, 1995). Levels of IGFs in the body have been shown to decrease in the third
decade of life, in parallel with decreases in growth hormone (GH) (LeRoith, 1992). This
leaves organs, such as the mammary gland, susceptible to xenobiotics that can exploit
signaling through this pathway, whether it is through direct activation by alterations in
downstream signaling molecules or by increased IGF and IGF-ER. activity. It is clear that
modulation of IGF-induced mitogenesis could have important implications in tumor
promotion/progression events in the development of breast carcinomas.
Therefore, TCDD and BaP were assessed for their ability to activate signaling
molecules associated with propagation of mitogenic signals due to ligand activation of
IGF-IR, in a manner which would explain the ability of these compounds to promote
growth in the MCF-10A cell line. The alterations produced by these compounds,
especially in relation to growth factor signaling pathways, could relate to their tumor
promoting activities.
86
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Figure 18. A schematic of insulin and insulin-like growth factor signaling and epidermal
growth factor signaling, including the signaling molecules that they share in common
(She). Both growth factors lead to cell proliferation by activation o f both common (ras)
and exclusive (IRS-1/PI3K) signaling molecules.
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MATERIALS AND METHODS

Chemicals and Reagents. All chemicals or reagents used were from Sigma
Chemical Co. (St. Louis, MO), unless otherwise indicated. The PAHs used in this study
included: benzo(a)pyrene (BaP), benzo(e)pyrene (BeP) with >95% purity as assessed by
the manufacturer. These chemicals were prepared weekly as stock solutions in anhydrous
tissue culture grade dimethyl sulphoxide (DMSO) and protected from light. The final
culture concentration of the DMSO in all experiments was 0.1% or less, except for
growth experiments using the PI3K inhibitor, in which the final concentration was 0.2%.
The PI3K inhibitor, LY294002, was prepared in DMSO and kept as a 25mM stock at 20°C. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased from Cambridge
Isotopes Labs (Andover, MA) at >99% purity. 3,3’,4,4’,5-pentachlorobiphenyl and
2,2\5,5’-tetrachlorobiphenyl were purchased from AccuStandard Inc. (New Haven, CT)
at >99% purity.
Culturing of MCF-10A. The culturing of MCF-10A cells was done according to
the procedure described in Chapter II.
Assay for Mitogenic Activity. The plating conditions, growth factor defined
conditions and counting method were previously described in Chapter II. 6 days of
treatment with TCDD +/- inhibitor were used, as previously employed for growth studies,
due to the limitations of growth in 6-well plates. For experiments using the addition of
the PI3K inhibitor LY29004, the inhibitor was added to cultures every other day in fresh
media changes, and all cultures contained 0.2% DMSO.
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Anti-phosphotyrosine Western Blots. Cells were placed in growth factordeprived media (SFH) for 8-11 h, and were then treated with compound in insulindeficient media (HE) for the indicated time. Cells were rinsed twice with ice cold Hank’s
BSS (Gibco BRL) and then lysed on ice with a buffer consisting of 50 mM Tris-HCl, pH
8.5,150 mM NaCl, 1 % Nonidet P-40 (ICN Biomedical, Inc., Aurora, OH), 5 mM EDTA
supplemented with 10 mM sodium pyrophosphate, 5 mM sodium orthovanadate, 50
pg/ml phenylmethysulfonyl fluoride (PMSF), 20 pg/ml aprotinin, and 10 pg/ml
leupeptin. Lysates were spun at 20,800 x g at 4°C for 10 mins. and then analyzed for
protein using a modified Lowry’s method. IGF-IR p subunit immunoprecipitation was
conducted from 2000-3000 pg whole cell lysates with 5 pg anti-IGF-IR a subunit
antibody (OncogeneResearch Products, Cambridge, MA) for 1 h at 25°C, with addition of
Protein G/Plus-agarose conjugate (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for
f

an additional hour. She immunoprecipitation was performed from 800-1000 pg of whole
cell lysates with 4 pg anti-Shc antibody (Upstate Biotechnology Incorporated) for 1 h at
25°C, with addition of Protein A-agarose conjugate (Santa Cruz Biotechnology, Inc.) for
an additional hour. IRS-1 immunoprecipitation was performed from 2000-3000 pg of

\
L

whole cell lysate with anti-IRS-1-agarose conjugate (Upstate Biotechnology
Incorporated, Lake Placid, NY) at room temperature for 2 h. IRS-1 and IGF-IR P subunit
immunoprecipitates were resolved on 7.5% polyacrylamide gels containing SDS and She
immunoprecipitates were resolved on a 10% gel, transferred to PVDF and probed with
the anti-phosphotyrosine antibody 4G10 (Upstate Biotechnology Incorporated).
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In general, 1-100 mm dish provides 800-1000 pg whole cell lysate protein. For IRS-1 and
IGF-IR immunoprecipitations, 1 or 2-150 mm dishes were used per sample, providing
2000-4000 pg of whole cell lysate protein.

PI3K Assay. Cells were grown to subconfluence in 100 mm dishes (Coming)
and were then placed in growth factor-deprived media (SFH) for 8 h, followed by PAH
or HAH treatment for 18 h. Cells were rinsed twice with ice cold Hank’s BSS (Gibco
BRL) and then lysed on ice with a buffer consisting of 20 mM Tris-HCl (pH 8.1), 137
mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 10% glycerol, 1% Nonidet P-40 (ICN),
supplemented with 30 mM sodium pyrophosphate, 150 mM sodium orthovanadate, 300
pg/ml phenylmethysulfonyl fluoride, 20 pg/ml aprotinin, and 10 pg/ml leupeptin.
Lysates were drawn through a 25 gauge needle two times, then spun at 20,800 x g at 4°C
i
|
•
i
:

for 10 min. and analyzed for protein, as described above. Immunoprecipitation of p85
was conducted by adding 3.75 pg of anti-p85 antibody (Transduction Laboratories,
Lexington, KY) to 1.2 mg of lysate at 4°C overnight, with addition of protein A-agarose
conjugate for 1 h at 4°C. Beads were washed two times with PBS (final pH 7.0)
containing 1% NP-40,200 pM sodium orthovanadate, 0.2 mM PMSF, 20 pg/ml
aprotinin, and 20 pg/ml leupeptin, then washed two times with 100 mM Tris-HCl (pH
7.5), 500 mM LiCl, 200 pM sodium orthovanadate, 0.2 mM PMSF, 20 pg/ml aprotinin,
and 20 pg/ml leupeptin, then washed two times with 10 mM Tris-HCl (pH 7.5), 100 mM
NaCl, 1 mM EDTA, 1 mM EGTA, and then washed two times with 20 mM HEPES (pH
7.5), 10 mM MgCl2, 0.5 mM EDTA. The kinase reaction was conducted with 200 pM La-phosphatidylinositol (Avanti, Alabaster, AL), 4.7 pM lithium salt ATP (Boehringer
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Mannheim, Indianapolis, IN), 96 pCi [y-32P]ATP (NEN Life Science Products, Boston,
MA), in reaction buffer (10 mM HEPES, 10 mM MgCl2, 0.5 mM EGTA, pH 7.7) for 30
min. at 37°C. 1M HC1 was added to stop kinase reaction. Lipid extractions were
performed with 1:2 CHCl3:MeOH and washed with 2 M KCL. Formation of y-32Pphosphatidylinositol 3-phosphate was quantified by liquid scintillation counting.
Statistical Design and Analysis. Data were analyzed for statistical differences
(p<0.05) between control and treated groups using SigmaStat statistical software (Jandel
Scientific, San Rafael, CA). ANOVA followed by Dunnett’s t-tests were performed on
sample means.
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RESULTS

BaP and TCDD increase tyrosine phosphorylation of IGF-IR p subunit.
Under the growth conditions used for routine culturing of MCF-10A, supraphysiological
concentrations of insulin are used to act as a ligand for IGF-IR, the receptor that mediates
the mitogenic effects of both insulin-like growth factors and insulin (Baserga & Rubin,
1993; LeRoith et al., 1994; Lowe, 1991). Since it is ligand-activation of this receptor at
the membrane level that initiates downstream signaling events, it was of interest to
determine if BaP and TCDD activate IGF-IR in a manner analogous to ligand activation.
Examination of the tyrosine phosphorylation status of the P subunit, which binds both
IRS-1, IRS-2 and She, would also determine if subsequent downstream docking
molecules might be activated. Time course examination of the tyrosine phosphorylation
of the p subunit induced by BaP and TCDD treatments showed that maximal activation
occurred between 1-2 h (Figure 19, lanes 2, 3, 5 and 6), an effect that was diminished by
4 h (Figure 19, lanes 8 and 9). The immunoprecipitation of other proteins in the 95 kD
region (due to low affinity/specificity of all commericially available anti-IGF-IR
antibodies) made quantitation o f changes in tyrosine phosphorylation of the P subunit
difficult.
Kinetics of tyrosine phosphorylation of She p66 and p52 by TCDD and BaP.
Two immediate downstream substrates of activated IGF-IR are She and IRS-1, both of
which bind to phosphorylated tyrosines on the p subunit, leading to increased tyrosine
phosphorylation of both She and IRS-1 (Myers et al., 1993; Pronk et al., 1993; Pronk et
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al., 1994). These two molecules then serve as docking proteins for SH2-containing
proteins that bind to tyrosine phosphorylated sites, propagating insulin-like growth factor
signaling (Myers et al., 1994; Skolnik et al., 1993). Time course studies were conducted
to assess changes in tyrosine phosphorylation induced by BaP and TCDD of She proteins
p66, p52 and p46, under insulin-deficient conditions (HE). Maximal tyrosine
phosphorylation for p52 and p66 induced by TCDD (Figure 20, lanes 4 and 8) and BaP
(Figure 20, lanes 2 and 7) was between 6-10 h (as determined by conducting this
experiment at least four or five times). Earlier and later time points revealed no changes
in the tyrosine phosphorylation state of any of the She proteins induced by BaP or TCDD
(data not shown). Little or no change in the tyrosine phosphorylation of p46 was seen at
any time point. The compounds 2,2’,5,5’ PCB and BeP treatment did not result in She
(p66, p52 and p46) tyrosine phosphorylation at any of the time points tested (Figure 20,
lanes 3, 5, 8 and 10).
BaP and TCDD increase tyrosine phosphorylation of IRS-1. Previous studies
showed that increased tyrosine phosphorylation of a 160-190 kD doublet from whole cell
lysates of MCF-10A was induced by both BaP and TCDD treatment (18 h) under insulindeficient conditions (Chapter II, Figures 14 and 15). Since it appears that both BaP and
TCDD may have IGF-I-mimetic properties and that IRS-1 migrates within the range of
160-190 kD, cells were treated with BaP or TCDD for 18 h and then assessed for
changes in tyrosine phosphorylation of IRS-1. Replicate 150 mm plates of cells treated
with DMSO, BaP and TCDD under insulin-deficient conditions (HE), showed increased
tyrosine phosphorylation or IRS-1 with both BaP and TCDD treatment (Figure 21, lanes
2, 3,4, and 5). Anit-IRS-1 blots of whole cell lysates confirmed that IRS-1 migrates as a
93
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Figure 19. Tyrosine phosphorylation of IGF-IR P subunit (95 kD) under insulindeficient conditions. MCF-10A cells were placed in growth factor-deprived media for 17
h and were then treated for 1,2 or 4 h with .3 pM BaP or 30 nM TCDD in HE media.
IGF-IR a subunit (130 kD) immunoprecipitation was performed from whole cell lysates.
The a subunit also immunoprecipitates the p subunit of the receptor, since they are linked
by a disulfide bond, but only the p subunit becomes tyrosine phosphorylated upon
t
\
f
I

activation. IRS-1 (165-185 kD), IRS-2 (-185 kD) and She (p46, p55 and p66) all bind to
the P subunit and become tyrosine phosphorylated, therefore IGF-IR immunoprecipitates

rt
*

I

could also pull down these tyrosine phosphorylated signaling molecules, explaining the

I
*

presence of multiple bands. Immunoprecipitates were resolved on a 7.5% gel, transferred
to a PVDF membrane, and probed with an anti-phosphotyrosine antibody (4G10). This is

I

a representative blot conducted at least twice.
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Figure 20. PAH- and HAH-induced tyrosine phosphorylation of She proteins (p46, p55
and p66) under insulin-deficient conditions. MCF-10A cells were placed in growth
factor-deprived media for 12 h and were then treated for 6 or 10 h with .3 pM BaP, .3 pM
BeP, 30 nM TCDD or 1 pM 2,2’,5,5’-tetrachlorobiphenyl in HE media. She
*

immunoprecipitation was performed from whole cell lysates, resolved on a 10% gel,
(

transferred to a PVDF membrane, and probed with an anti-phosphotyrosine antibody

|

(4G10). Results shown are from a representative experiment conducted at least four
times.

i
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doublet between 160-185 kD. Quantitation revealed that BaP treatment produced almost
a 2-fold increase in both the top and bottom IRS-1 bands. TCDD treatment caused a 2fold and 3-fold increase in the top and bottom IRS-1 bands, respectively. Interestingly,
IRS-1 is tyrosine phosphorylated by BaP and TCDD after an 18 h treatment, an effect not
seen with She (data not shown). Examination of changes in the tyrosine phosphorylation
of the 160-190 kD doublet in whole cell lysates did not reveal any differences induced by
BaP or TCDD at earlier time points (data not shown). IRS-1 appears as a doublet under
these experimental conditions, possibly due to differences in the phosphorylation status
of IRS-1, since it is also very highly serine and threonine phosphorylated (Myers et al.,
1994).
Increased PI3K activity induced by TCDD and BaP. PI3K activation occurs
tt
(
|
I
•
|
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?
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immediately downstream of IRS-1. Since tyrosine phosphorylation of IRS-1, induced by
both BaP and TCDD, was seen after an 18 h treatment, PI3K assays were conducted
under the same conditions. Cells were treated in HE media for 18 h in the presence of
DMSO (vehicle control), BaP or TCDD. Significant activity was induced with TCDD

r.

j

«_

treatment (212% increase), and to a lesser extent with BaP (44% increase) (Figure 22), as
assessed by y-32P phosphorylation of the substrate phosphatidylinositol.
PI3K-dependence for TCDD-induced mitogenesis. To confirm that activation
of PI3K, as shown in Figure 21, leads to the previously observed TCDD-induced growth
promotion under insulin-deficient conditions (Chapter II, Figure 13), a specific PI3K
inhibitor, LY294002, was used in growth studies. Serum-free media supplemented with
hydrocortisone and epidermal growth factor (HE) was used to assess the impact that PI3K
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Figure 21. BaP- and TCDD-induced tyrosine of IRS-1 under insulin-deficient
conditions. MCF-10A cells were placed in growth factor-deprived media for 8 h and
were then treated for 18 h with .3 uM BaP or 30 nM TCDD in HE media. IRS-1
!

i
*
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■
■

immunoprecipitation was performed from whole cell lysates, resolved on a 7.5% gel,
transferred to a PVDF membrane, and probed with an anti-phosphotyrosine antibody
(4G10). Results shown are from an experiment conducted at least three times.
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i

inhibition has on TCDD-induced growth. 6 day TCDD treatment lead to a 36% increase
in growth under insulin-deficient conditions (Figure 23). Inhibitor control cultures did
show a slight increase in cell recovery that was statistically significant, but subsequent
experiments did not show any difference between DMSO and inhibitor controls (data not
shown). Addition of LY294002 to TCDD-treated cultures abolished the growth effect
seen in non-inhibited cultures. Concentrations of LY294002 used to inhibit TCDDinduced proliferation were first used to inhibit growth of MCF-10A under IHE
conditions, to confirm that the mitogenic effects of insulin could be blocked within a
range of concentrations (data not shown). This clearly indicates that the TCDD-induced
increase in PI3K activity leads to the mitogenic effects observed after long-term TCDD
treatment.
|
i
j,

HAHs modulate cell growth in the MCF-10A cell line. We have shown
previously that TCDD, and to some extent, BaP, increase MCF-10A cell proliferation

*

under insulin-deficient conditions (Chapter II, Figure 13). Since TCDD has been shown
f
•'

to stimulate growth 67% above control under this condition (Chapter II, Figure 13), it

I

was o f interest to determine whether this is an AhR-dependent effect by comparing it to
the growth effects of two PCBs: 3,3’,4,4’,5-pentachlorobiphenyl and 2,2’,5,5’tetrachlorobiphenyl. 3,3’,4,4’,5 PCB has strong affinity for the AhR compared to the
inactive compound 2,2’,5,5’ TCB, but has much lower binding affinity than the most
potent agonist, TCDD. In the present studies, a serum-free media developed by Ethier et
al. (Ethier & Moorthy, 1991; Ethier et al., 1991) supplemented with insulin (I),
hydrocortisone (H), and epidermal growth factor (E) was utilized to determine whether
HAHs alter cell growth of MCF-10A cells under growth factor-defined conditions.
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Figure 22. Modulation of PI3K activity by TCDD and BaP treatment under insulindeficient conditions. MCF-10A cells were placed in growth factor-deprived media for 8
h and were then treated for 18 h with .3 pM BaP or 30 nM TCDD in HE media. Whole
cell lysates were prepared as described in Materials and Methods. p85
immunoprecipitation was performed, and then reacted with phosphatidylinositol, lithium
»
salt ATP, and y-32P-ATP for 30 min. Lipid extractions were performed as described in
ii
|

Materials and Methods and product counted by liquid scintillation. Results shown are the

;

mean +/- SE from a single experiment performed in quadriplicate. * indicates a

'

significant increase as compared to DMSO control (p< 0.05). This experiment is a
representative experiment conducted at least three times.
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Figure 23. Inhibition of TCDD-induced cell proliferation by a PI3K inhibitor under
insulin-deficient conditions. MCF-10A cells were initially plated in insulin-deficient media
CHE). The plating efficiency was determined by counting cell nuclei 24 h after plating cells,
at which time cells were treated with TCDD (30 nM) or TCDD + LY294002 (10-25 pM).
Cell growth was assessed 6 days after treatment by counting isolated nuclei, as described
in Methods. Results shown are the Mean + SE for cell counts obtained from triplicate
cultures for a representative experiment. * indicates a significant increase from DMSO
control and & indicates a significant difference as compared to TCDD treatment (p<
0.05).

100a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10

SFHE

100b

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

MCF-10A cells grown in complete media (IHE) were found to have a slight, but
significant, increase in cell growth after 6 days of treatment in the presence of TCDD (30
nM), whereas the two PCBs had no effect on cell growth in IHE media (Figure 24).
Little change in cell proliferation was found after treatment with either TCDD, 3,3’,4,4’,5
or 2,2’,5,5’ PCB under EGF-deficient conditions (IH). In insulin-deficient media (HE
media), TCDD (30 nM) produced a significant increase in MCF-10A cell growth (33%).
However, while neither PCB caused an increase in growth, at 0.1 pM, both PCBs caused
a significant decrease in growth, suggesting that AhR affinity does not seem to correlate
with the ability to promote growth under insulin-deficient conditions.
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Figure 24. Growth effects of TCDD and PCBs in MCF-10A cells. MCF-10A cells were
initially plated in one of three growth factor defined conditions: serum-free complete
media containing insulin (I), hydrocortisone (H), and epidermal growth factor (E) - IHE,
epidermal growth factor-deficient media (IH), or insulin-deficient media (HE). The
plating efficiency was determined by counting cell nuclei 24 h after plating cells, at
which time cells were treated with TCDD (30 nM), 3,3’,4,4’,5-pentachlorobiphenyl or
f

j
ii

2,2’,5,5’-tetrachlorobiphenyl (0.1-1.0 pM). Cell growth was assessed 6 days after

[

treatment by counting isolated nuclei, as described in Methods. Results shown are the

r

Mean ± SE for cell counts obtained from triplicate cultures for a representative

i

experiment repeated on at least three occasions. * indicates a significant increase and +
indicates a significant decrease as compared to DMSO control (p< 0.05).
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DISCUSSION

In the present study, two potent carcinogens, TCDD and BaP, were assessed for
their ability to produce alterations in the insulin-like growth factor receptor-I signaling
pathway, under insulin-deficient conditions. The growth promoting effects of BaP and
TCDD under insulin-deficient conditions have been previously demonstrated (Chapter II,
Figure 13). Increased tyrosine phosphorylation of several proteins in MCF-10A whole
cell lysates were seen after 18 h treatments with both BaP and TCDD under insulindeficient conditions (Chapter II, Figures 14 and 15). The changes in the tyrosine
phosphorylation of several proteins may be due to increased tyrosine kinase activity
and/or decreased tyrosine phosphatase activity induced by BaP and TCDD. Previous
*
’

studies showed that herbimycin A pretreatment blocked the ability of BaP and BaP-7,8dihydrodiol to increase tyrosine phosphorylation of several proteins, but not all the
proteins that showed increased tyrosine phosphorylation were affected (Chaper II, Figure

£

X
t

17). Therefore it is likely that both tyrosine kinase activation and tyrosine phosphatase

,

inhibition, activation of both which normally keep a balance in the tyrosine

:

phosphorylation state of many proteins involved in signaling, may be mechanisms by

j

which BaP and TCDD produce alterations in the IGF-IR signaling pathway, perhaps

•

leading to changes in cell proliferation. Therefore, several proteins associated with IGFIR signaling were for changes in activation induced by BaP and TCDD.
Studies were performed to determine whether BaP and TCDD could mimic IGF
signaling by causing increased tyrosine phosphorylation of the p subunit of the receptor,
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in a manner analogous to ligand activation of the receptor. BaP and TCDD both
produced changes in the tyrosine phosphorylation of the P subunit (95 kD), indicating
that downstream signaling molecules could also be affected through SH2 domain binding
to the p subunit and subsequent downstream propagation of a mitogenic signal.
Interestingly, other IGF-IR downstream signaling molecules appear to be
immunoprecipitated with the IGF-IR, as demonstrated by several phosphorylated tyrosine
bands, in the 185-200 kD range (probably IRS-1 and IRS-2), and the 46-90 kD range
(probably She family proteins).
While it has been shown that She binding to a phosphotyrosyl site on the p
subunit of IGF-IR leads to tyrosine phosphorylation of this adaptor, She tyrosine
phosphorylation is not unique to IGF and insulin signaling (Pellici et al., 1992; Pronk et
I

al., 1993; Pronk et al., 1994; Sasaoka et al., 1994). She can also bind to phosphotyrosyl

i

•
£
|

sites on the cytoplasmic tail of EGFR, leading to ras activation through Grb2-Sos
interaction (Pronk et al., 1994). Therefore, it is likely that the relatively small increases
in tyrosine phosphorylation of p66 and p52 seen at 6-10 h induced by BaP and TCDD
treatment, may lead to mitogenesis in an amplified manner downstream o f ras activation,
since studies have pointed to a more important role for She than IRS-1 in relation to ras
activation (Ouwens, 1994).
While the changes seen in tyrosine phosphorylation of She were slight, those of
IRS-1 were large in comparison, due to the fact that IRS-1 is specific to insulin and IGF
signaling in the MCF-10A cell line. BaP and TCDD both significantly increased the

tyrosine phosphorylation of a doublet corresponding to IRS-1. In our studies,
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immunoprecipitated IRS-1 appeared as a doublet, most likely due to its serine and
threonine phosphorylation. There is also the possibility of cross-reactivity o f the
antibody with IRS-2, a highly related protein of similar size. While activation of IRS-1
probably doesn’t lead to strong mitogenic signaling through the ras/MEK/MAPK
pathway (Ouwens, 1994; Sasaoka et al., 1994), it can activate PI3K, an enzyme which
leads to production of lipid second messengers involved in both mitogenesis and cell
survival (Toker & Cantley, 1997; Varticovski et al., 1994). Although it is questionable as
to whether PI3K is activated downstream of EGFR in a physiologically relevant manner,
it has been shown that it is important downstream of both IR and IGF-IR in normal
signaling (Myers et al., 1992; Myers et al., 1994; Varticovski et al., 1994). Therefore,
the ability of TCDD to induce strong activation of PI3K, while BaP only slightly
increased activity, seems to point to a mechanism for the differences seen between the
growth promoting effects of these compounds. Use of the PI3K inhibitor, LY294002,
reduced TCDD-induced mitogenesis under insulin-deficient conditions, supporting the
fact that PI3K activation is necessary for the growth promoting effects of TCDD.
The mechanism by which BaP and TCDD increase tyrosine phosphorylation of
IGF-IR and downstream signaling molecules may be due to changes in the redox status of
the cell. Interestingly, it has been shown that protein tyrosine kinases may be activated
by redox-active agents (Schieven et al., 1993). Other investigators have shown that
oxidative agents, such as pervanadate, increase insulin signaling in skeletal muscle cells
(Tsiani et al., 1997). The involvement of reactive oxygen species, particularly in relation
to tumor promoting activities, has been well established by several studies. Organic
peroxides and hydrogen peroxide have been shown to be mouse skin tumor promoters
105
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(Clemens, 1991). The in vitro and in vivo tumor promoting activity of TPA is associated
with hydrogen peroxide production and oxidative DNA damage (Fischer et al., 1988; Wei
& Frenkel, 1993; Wei et al., 1993), while non phorbol ester-type promoters, including
TCDD, have been shown to induce the formation of reactive oxygen species (ROS) as
well (Ogawaef al., 1995; Scholz et al., 1990; Stohs, 1990; Stohs etal., 1990). The
production of ROS may be a common mechanism utilized by both phorbol ester and nonphorbol ester tumor promoters, as demonstrated by the blockade of the tumor promoting
activities of both TPA and TCDD by antioxidants in initiated mouse fibroblasts (Wolfle
& Marquardt, 1996).
TCDD has been shown to induce oxidative stress by enhanced in vitro and in vivo
hepatic and extrahepatic lipid peroxidation (Al-Bayati et al., 1987; Alsharif et al., 1990;
Hassan et al., 1985), decrease hepatic membrane fluidity (Alsharif et al., 1990), decrease
glutathione content (Stohs et al., 1990), increase nuclear and peritoneal DNA damage
(Alsharif et al., 1994), decrease non-protein sulfhydryl and NADPH content (Stohs et al.,
1990) and increase superoxide anion production from peritoneal lavage cells after in vivo
administration to rats (Alsharif et al., 1994). Oxidative metabolism of PAHs, like BaP,
results in release of reactive intermediates such as superoxide anion radicals, singlet
oxygen and hydrogen peroxide (Frenkel et al., 1988), as well as formation of metabolites
that can undergo redox cycling (Lorentzen & Ts'o, 1977), all of which can cause
oxidative DNA damage and form DNA adducts (Jerina et al., 1991; Leadon et al., 1988).
Leadon et al. (1988) have previously demonstrated that BaP metabolism in human
mammary epithelial cells leads to generation of reactive oxygen molecules and ensuing
oxidative DNA damage, as measured by thymine glycol production, a result sensitive to
106
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superoxide dismutase. Thus, further studies will be aimed at evaluating the redox status
o f MCF-10A following exposure to carcinogenic PAHs.
In summary, BaP and TCDD were found to increase the tyrosine phosphorylation
o f IGF-ER p subunit, with subsequent increases in the tyrosine phosphorylation of the
downstream signaling molecules She and IRS-1. Increased tyrosine phosphorylation of
ERS-1 appears to lead to increased activation of PI3BC, induced by both BaP and TCDD,
in relation to the differences in the growth promoting activities of the compounds under
insulin deficient conditions. Thus, these results suggest that BaP and TCDD may activate
protein tyrosine kinases and/or inhibit phosphatases, effects that may lead to the IGF-like
signaling of these compounds and subsequent increased MCF-10A growth in a PI3Kdependent manner.
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GENERAL DISCUSSION

With the incidence of breast cancer cases on the rise, and with the known risk
factors only accounting for a small proportion of these cases, it appears likely that
environmental factors may play a role in the etiology of the disease (Jahnke & Barrett,
1996). A number of potentially carcinogenic chemicals are widespread in the
environment, and have been shown to cause mammary tumors in laboratory animals
(Dunnick et al., 1995; Wolff et al., 1996). Most of these chemical carcinogens require
metabolic activation to electrophilic species which then interact covalently with DNA
(Shaw & Connell, 1994). The identification of risk factors, such as polymorphisms in
xenobiotic metabolism, may be important in the prevention and treatment of the disease
i
(Bartsch & Hietanen, 1996; Smith et al., 1994).
Previous studies have demonstrated the importance o f both BaP and BaP
metabolites in relation to breast cancer etiology. Gould et al. (1986) showed, using
C

mutagenesis assays with both rat and human mammary epithelial cells, that DMBA was
more mutagenic than BaP in the rat mammary cell culture system while BaP was more
mutagenic that DMBA in the human mammary epithelial cell culture system. These
results suggest a role for BaP as an initiator of human mammary epithelial cells (Gould et
al., 1986). Stampfer et al. (1981) showed the presence of 7,8-diol-9,10-epoxide-BaPDNA adducts in primary cultures o f human mammary epithelial cells 6 hours after the
addition of the parent compound, BaP, to cultures. A similar experiment conducted in
pure fibroblastic cultures obtained from the same mammary epithelial cell donors showed
the same extent and type of diol-epoxide-DNA adducts as the epithelial cells, suggesting
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that PAH metabolism to mutagenic metabolites is not solely due to the small population
of epithelial cells that reside within the breast. It is also believed that metabolism to
electrophilic compounds is accompanied by production of reactive oxygen species, which
themselves can cause oxidative DNA damage, contributing to the carcinogenicity of
PAHs, such as BaP. The detection of thymine glycols, one type of oxidative DNA
damage, was found in human mammary epithelial cells, after addition of BaP to cultures.
The number of thymine glycols seemed to correlate with number of 7,8-diol-9,10epoxide-BaP-DNA adducts, but only the formation of thymine glycols was sensitive to
superoxide dismutase addition to cultures (Leadon et al., 1988).
Previous studies on PAHs have focused on the ability of PAH metabolites to
interact with DNA and to form adducts and cause oxidative damage. However, it is clear
that PAH metabolites also have the ability to form adducts and to produce oxidative
effects on cellular proteins, including those involved in various signaling pathways and
associated with maintenance of calcium homeostasis. Work in our lab has shown that
BaP metabolites, including BaP 7,8-diol and BaP 7,8-diol-9,10-epoxide, are potent
inducers of Ca2+elevation in HPBMC and Daudi human B cells (Mounho et al., 1997;
B.Mounho & S.Burchiel, submitted). In these studies, the Ca2+elevating effects of BaP
and BaP-7,8-diol were prevented by pretreatment of cells with ANF, a P450-1A and IB
inhibitor. It appears that the mechanism of Ca2+elevation in HPBMC and Daudi is due to
the formation of BaP metabolites that produce oxidative damage to redox-sensitive
signaling proteins controlling Ca2+ homeostasis in lymphocytes. Oxidative damage
produced by BaP metabolites was directly demonstrated by GSH depletion in HPBMC
(Romero et al., 1996). In addition, recent studies demonstrated that BaP 7,8-diol-9,10109
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epoxide induced NF-kB nuclear translocation in Daudi human B cells, an effect
associated with oxidative damage in lymphocytes (Salas et al., in preparation). Since
BaP metabolites are more potent than BaP in elevating Ca2+ in MCF-10A, we suspect that
metabolism of BaP to reactive metabolites and subsequent oxidative damage may also
play an important role in altered Ca2+ homeostasis in HMEC and MCF-10A.
There are, however, important differences in the alterations in Ca2+ homeostasis
seen in the lymphocyte models discussed above, and the human mammary epithelial cell
systems evaluated in the present studies. First, it was found that ANF only partially
prevented Ca2+elevation produced by BaP in MCF-10A cells. Therefore, PAH 1A or IB
metabolism, which are both sensitive to inhibition by ANF, is not likely to completely
explain the effects of BaP and other PAHs on alterations in Ca2+homeostasis. In addition,
the growth promoting effects of PAHs and TCDD seen in insulin-deficient media did not
;
L
t
\

appear to correlate with alterations in Ca2+ homeostasis. Therefore, it is important to

.

homeostasis and cell growth in human mammary epithelial cells compared to human

consider potential differences between the effects of PAHs and TCDD on altered Ca2+

lymphoid cells.
■

Work done in the Jefcoate lab has shown that DMB A metabolism, both in the rat

i

and human mammary system, is largely a consequence of IB 1 metabolism in stromal
fibroblasts (Christou et al., 1995; Larsen & Jefcoate, 1997). Our culture system for
HMEC did not result in the growth of significant numbers of stromal fibroblasts. In
addition, the MCF-10A is a clonal cell line that grows independent of feeder cells.
Therefore, we cannot directly speculate on the metabolism of PAH by HMEC and MCF-
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10A in terms of the types and amounts of metabolites formed in our culture systems.
These studies are planned for future evaluation. However, the fact that ANF did produce
a statistically significant decrease in the Ca2+elevating effects of BaP in HMEC and
MCF-10A does suggest that P450 metabolism is likely to play some role in signaling in
our model systems.
The results from BaP- and TCDD-induced cell proliferation under growth factor
defined conditions point to two mechanisms of action for these compounds as mitogens
or anti-mitogens. The ability of TCDD to promote growth to a greater extent than BaP
under HE (insulin-deficient) conditions points to a potential AhR-dependent mechanism.
The mitogenic effects on growth did not appear to correlate with the ability o f these
compounds to alter intracellular Ca2+ levels in MCF-10A. The ability of BaP to inhibit
f

growth in complete media (IHE) in a dose-dependent manner, while TCDD has no

;

positive or negative effect on growth under these conditions, suggests that another

«i
1

mechanism may be responsible.

ir.

\

The anti-mitogenic effects of BaP in MCF-1OA in complete media may relate to
the increase in intracellular Ca2+. BaP was able to increase intracellular Ca2+ in MCF-1 OA

I
|

in both a time- and dose-dependent manner, while TCDD had no significant effect on
Ca2+at any time point. The Ca2+experiments were conducted under complete media

!

■

conditions (IHE), using 3 and 0.3 pM BaP and 30 nM TCDD, the same conditions used
to assess growth in IHE conditions, therefore allowing a possible correlation between
these two effects to be drawn. It could be that the ability of BaP to produce sustained
alterations in Ca2+ (up to 72 h treatments were evaluated and proved to be significant)

ill
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could lead to cellular signaling shut down, since there is such dysregulation of this
important second messenger. Since TCDD didn’t affect intracellular Ca2+signaling in
MCF-10A cells, this could be why there was no anti-mitogenic effect observed for this
compound under IHE conditions. No Ca2+ experiments were conducted under HE
conditions, but it could be that there are differences in the ability to alter intracellular Ca2+
under these conditions, especially if there is indeed a role for BaP metabolites in relation
to Ca2+ alterations (as our studies suggest). Differences in serum and growth factor
conditions have been previously shown to affect AhR expression, and presumably P450
induction (Vaziri et al., 1996), the enzymes responsible for BaP metabolism. In fact,
clinical studies utilizing an agent that alters Ca2+homeostasis and dysregulates signal
transduction pathways that utilize Ca2+as a second messenger are under way to inhibit
\

cancer ceil proliferation (Cole & Kohn, 1994).

I

■

If alterations in intracellular Ca2+ induced by BaP and TCDD explains differences

v

5

I

in growth between these two compounds, the question arises as to whether another
mechanism involving AhR is responsible for the observed alterations in cell growth

*
j
•

(specifically under HE conditions). In this case, the differential effects of BaP compared
to TCDD might be explained by differences in AhR affinity. Use of 3,3’,4,4’,5’pentachlorobiphenyl to assess AhR ligand-induced growth under insulin-deficient
conditions showed that being an AhR ligand is not sufficient for growth promotion in
MCF-10A. Therefore, these studies leave open the possibility that the AhR may play
some role in growth promotion in MCF-10A cells. However, since it is known that
TCDD and other PAHs produce both AhR-dependent and AhR-independent effects
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(Beebe et al., 1990; Bombick et al., 1988; Bombick et al., 1985; Nebert, 1989) the role of
AhR in signaling o f growth must be further evaluated, perhaps using genetic approaches.
There are several previous studies that demonstrate that TCDD and PAHs may
have important effects on cell signaling and growth, some of which have been correlated
with alterations in Ca2+ signaling and/or oxidant-induced injury. Puga et al. (1992) found
that TCDD induced a transient increase in Ca2+, elevation of activated, membrane-bound
PKC, induction of c-fos and c-jun family members and increased AP-1 transcription
factor activity. Induction of c-fos, c-jun, Jun-D and Jun-B after TCDD treatment was
maximal between 2.5-4.5 h, and increased AP-1 activity for TCDD was seen after 4 h.
BaP treatment induced Jun-D and Jun-B after a 2 hour treatment. Induction of c-fos and
Jun-B by TCDD was not dependent on a functional AhR or ARNT, as demonstrated in
I

two mutant cell lines. As suggested by the authors, the AhR may not play a role in early

i
.f

events, such as gene induction, but may have a function at later times. Such an

i

t

explanation would support our observations that BaP and TCDD have similar effects on

f
’

tyrosine phosphorylation of signaling molecules in the insulin-like growth factor
pathway, but the involvement of AhR-dependent effects latter in the sequence of
carcinogen-induced signaling alterations leads to differences seen in growth promoting
effects of the two compounds in both MCF-10A and HMEC.
In a similar study to that reported above, Hoffer et al. (1996) further characterized
how TCDD induces immediate-early genes by attaching different response elements from
c-fos and c-jun family member genes to a reporter gene. TCDD induced luciferase
expression when TPA response element (TRE), serum response element (SRE) and Ah
response element (AhRE)/dioxin response element (DRE) from c-jun and Jun-D were
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attached to the reporter gene, an effect that was competed away by CYP1 Al AhRE. In a
cell system that lacks AhR, c-fos SRE-containing expression plasmids responded equally
to TCDD whether or not AhR and ARNT were coexpressed (Hoffer et al., 1996),
suggesting that TCDD can induce c-fos expression in an AhR-independent manner. SRE
induction of c-fos can also be induced by growth factors, UV irradiation, oxidants and
other stimuli that activate MAPK (Karin, 1995). It is likely that TCDD’s effects on SREs
may be mediated by a signal initiated at an upstream signaling molecule, preceding AhR
binding, since TCDD has been shown to activate tyrosine kinases (Beebe et al., 1990;
Bombick et al., 1988; Bombick et al., 1985), ras (Enan & Matsumura, 1995; Madhukar et
al., 1984; Tullis et al., 1992), and src (Enan & Matsumura, 1996), all o f which can lead to
MAPK activation. Activation of AP-1 members by TCDD seems to be complex, owing
to the fact that several response elements from several different AP-1 family members are
activated by TCDD, in an AhR-dependent and -independent manner. The effects of BaP
on induction of different family members was not assessed, but the study by Hoffer et al.
seems to point to a role for TCDD as a potent mitogen if TCDD can activate SREs in an
AhR-independent manner.
Another study by Enan & Matsumura (1995), showed that TCDD is able to cause
rapid increases in protein kinase activation in an AhR-dependent fashion, but without
transcriptional activation, and causes stimulation of MAPK and protein tyrosine kinases
in an equally rapid manner, indicating that TCDD activates protein kinase mediated
growth factor signaling pathways. This could point to a mechanism by which TCDD and
BaP, as AhR ligands, activate protein kinases according to binding affinity, but possibly
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under certain conditions when there is not already maximal kinase activation being
stimulated by plateau levels of growth factors, as is the case in IHE media for MCF-10A.
There are other differences between BaP and TCDD besides AhR binding
affinities that may contribute to differences in the ability of these two compounds to alter
intracellular signaling. The halogenated nature of TCDD makes this compound very
resistant to enzymatic oxygenation. The oxidative metabolism of TCDD occurs 30,000
times more slowly than that of BaP. TCDD has been shown to induce oxidative stress by
enhanced in vitro and in vivo hepatic and extrahepatic lipid peroxidation (Al-Bayati et al,
1987; Alsharif et a l, 1990; Hassan et a l, 1985), decreased hepatic membrane fluidity
(Alsharif et a l, 1990), decreased glutathione content (Stohs et a l, 1990), increased
nuclear and peritoneal DNA damage (Alsharif et al, 1994), decreased non-protein
sulfhydryl and NADPH content (Stohs et a l, 1990) and increased superoxide anion
production from peritoneal lavage cells after in vivo administration to rats (Alsharif et al,
1994).
Oxidative metabolism of PAHs, like BaP, results in release o f reactive
intermediates such as superoxide anion radicals, singlet oxygen and hydrogen peroxide
(Frenkel et a l, 1988), as well as formation of metabolites that can undergo redox cycling
(Lorentzen & Ts'o, 1977), all of which can cause oxidative DNA damage and form DNA
adducts (Jerina et a l, 1991; Leadon et al., 1988). Leadon et a l have previously
demonstrated that BaP metabolism in human mammary epithelial cells leads to
generation o f reactive oxygen molecules and ensuing oxidative DNA damage, as
measured by thymine glycol production, a result sensitive to superoxide dismutase
(Leadon et a l, 1988).
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TCDD has been shown, in a study by Yao et al. (1995), to induce long terminal
repeat driven CAT expression in a CYP1 Al -dependent manner, an effect abolished by
NF-kB or ARE mutation in the LTR sequence. TCDD-induced CAT expression was
sensitive to JV-acetyl-L-cysteine (NAC), an oxidant scavenger and contributor to GSH
production, and 2-ME pretreatment, suggesting that TCDD-induced LTR-driven CAT
expression might involve CYP1A1-dependent oxidative stress. P450-dependent
epoxygenation of arachidonic acid can lead to incorporation of epoxyarachidonoyl lipids
into membranes, resulting in various changes in membrane microenvironment and
function, an effect that could change the oxidant status of the cell as well as membraneinitiated signaling (Capdevila et al., 1992). Hydrogen peroxide has been shown to induce
activation of NF-kB, an effect which is sensitive to NAC (Schreck et al., 1991; Staal et
|

al., 1990). Therefore, it is possible that a change in the oxidant status of a cell, induced

I

by CYP1A1 metabolism, is responsible for the TCDD-induced CAT expression, an effect

■

also dependent on the presence of a NF-kB recognition sequence in the LTR. If TCDD,

r

'

and BaP through it’s own metabolism (Jerina et al., 1991; Leadon et al., 1988; Yao et al.,
1995)

and glutathione depletion (Romero et al., 1997; Yuan et al., 1994) can both

t

a change in the oxidant status of a cell, then changes in transcriptional activation could be

I
\
•

effected, as demonstrated by Yao et al. (1995). The mechanism could be distinct from
AhR-ARNT activation of ARE-containing genes, or act in combination/synergy.
The involvement of reactive oxygen species, particularly in relation to tumor
promoting activities, has been well established by several studies. Organic peroxides and
hydrogen peroxide have been shown to be mouse skin tumor promoters (Clemens, 1991).
The in vitro and in vivo tumor promoting activity of TPA is associated with hydrogen
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peroxide production and oxidative DNA damage (Fischer et al., 1988; Wei & Frenkel,
1993; Wei et al., 1993), while non phorbol ester-type promoters, including TCDD, have
been shown to induce the formation of reactive oxygen species (ROS) as well (Ogawa et
al., 1995; Scholz et al., 1990; Stohs, 1990; Stohs etal., 1990). The production of ROS
may be a common mechanism utilized by both phorbol ester tumor promoters and nonphorbol ester tumor promoters, as demonstrated by the blockade of the tumor promoting
activities o f both TPA and TCDD by antioxidants in initiated mouse fibroblasts (Wolfle
& Marquardt, 1996).
Another well-defined role for oxidative stress is as mechanism for protein tyrosine
phosphatase (PTP) inhibition. Vanadium-based PTP inhibitors have been shown to be
redox-active compounds, which cause rapid accumulation of tyrosine phosphorylated
proteins and activation of src family kinases in T lymphocytes (Imbert et al., 1994;
Oetken et al., 1994). Another activity of vanadium-based PTP inhibitors is as insulinmimetic compounds (Tsiani et al., 1997). Therefore, unlike the study above which points
to a role for oxidative stress-induced transcriptional activation, oxidative stress can lead
to PTP inhibition with subsequent augmentation of tyrosine kinase signaling and insulinmimetic signaling, either directly through activation of insulin receptor kinase activity
(Fantus et al., 1989; Kadota et al., 1987), or indirectly through PTP inhibition. Treatment
of rat hepatocytes with a peroxovanadium compound was found to inhibit the mRNA of
IGF binding proteins (IGFBP) 1 and 4 in a MAPK-dependent manner (Band & Posner,
1997). This indicates that generation of oxidative stress can generate insulin-mimetic
effects, as well as augment insulin-like signaling through decreased production of
IGFBPs. This mechanism greatly supports the role for BaP- and TCDD-induced cell
117
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proliferation under HE (insulin-deficient) conditions, since both compounds can cause
changes in the oxidant status o f the cell, an effect which seems to have important
implications in the insulin-like growth factor pathway.
Clearly more studies need to be done in order to better assess the mechanism by
which TCDD and BaP cause activation of the IGF-IR signaling pathway. If oxidative
stress is involved, then use of anti-oxidants would be expected to abolish the activation of
signaling molecules involved in mitogenesis. Examination of phosphatase inactivation
associated with growth factor signaling pathways would also provide mechanistic
evidence. The significance o f the alterations in intracellular Ca2+ levels induced by
carcinogenic PAHs in both MCF-10A and HMEC still needs to be determined in relation
to cell signaling pathways. Down-modulation of PKCs due to sustained Ca2+alterations
S
>

may be involved in the dysregulation of cell signaling systems induced by PAH

i.

\

treatment. The magnitude and duration of the alterations in Ca2+homeostasis observed
may indeed lead to dysregulation of cell signaling systems in general. It could be that

i

£•

lower levels of PAHs produce more biologically relevant alterations in cell signaling that
r

are significant to the role that these compounds play as complete carcinogens, but that

fc.

«•

j
!

normal cell signaling regulators keep such alterations to a minimum, emphasizing the
difficulties in using normal cells to study neoplastic transformation.

i

!

O f interest, recent unpublished data has suggested that upregulation of erbB
family members in human mammary cells is induced by TCDD treatment (C. Jefcoate,
personal communication). MCF-10A has low levels of erbB-2 and erbB-3 expressed, but
probably at insufficient levels to stimulate PI3K. If TCDD treatment can upregulate
sig n a lin g

molecules to significant levels, then it is possible that non-traditional signaling
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pathways are created within a cell system, such as erbB-2/erbB-3 heterodimers activating
PI3K and bypassing the requirement of exogenous insulin for normal activation o f this
system. Efforts to identify molecular mechanisms of action of both BaP and TCDD
could alleviate some of the difficulties involved with evaluating long term effects, such as
cell growth, in relation to cell signaling alterations in normal cell systems.
In summary, a major observation of these studies was that carcinogenic PAHs
produced a dose- and time-dependent increase in intracellular Ca2+ in both HMEC and
MCF-10A. The ability to induce alterations in Ca2+homeostasis in MCF-10A did not
correlate with the ability to promote growth, as demonstrated by BaP and TCDD
treatment of growth factor defined cultures. Future studies are aimed at determining if
the Ca2+ alterations observed correlate with the ability of the compounds to alter the
?

differentiation o f mammary epithelial cells. It has been demonstrated that the

I

differentiation status of the mammary gland influences its susceptibility to chemical

'

carcinogens (Nandi et al., 1995).
The lack of correlation between the growth promoting effects of TCDD and
alterations in intracellular Ca2+homeostasis led to a second significant observation in

;

these studies; namely, the ability of TCDD and BaP to induce the proliferation of MCF-

i
!

10A under insulin-deficient conditions. Both compounds appeared to mimic insulin-like

j

growth factor signaling by increasing the tyrosine phosphorylation of IGF-IR, She and
IRS-1, in a manner similar to ligand activation. Increased PI3K was shown to be
significantly increased by TCDD treatment, and only slightly increased by BaP treatment,
an effect that correlates with the growth promoting capability of these compounds. To
confirm that PI3K activation can lead to mitogenesis in this system, use of a PI3K
119
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inhibitor, LY294002, was shown to significantly decrease TCDD-induced mitogenesis in
MCF-10A under insulin-deficient conditions. Alterations induced by BaP and TCDD in
this important growth factor signaling pathway probably point to a mechanism of action
for these compounds as tumor promoters. These alterations may also be physiologically
relevant, since the majority of IGFs are produced in the liver and sequestered in the
circulation by IGFBPs, suggesting that very low levels of free IGFs are available to
interact with the mammary gland (LeRoith, 1997). Therefore, a physiologically
important mechanism of action has been potentially identified for these carcinogenic
compounds that may help us understand how tumor promoters work in the complex,
multistage genesis of cancer.
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ABBREVIATIONS

AhR

aryl hydrocarbon receptor

ANF

a-naphthoflavone

Anth

anthracene

ARE

Ah receptor response element

ARNT

aryl hydrocarbon receptor nuclear translocator protein

ATP

adenosine 5’-triphosphate

BA

benz(a)anthracene

BaP

benzo(a)pyrene

BeP

benzo(e)pyrene

BPDE

benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide

Ca2+

calcium

DAG

diacylglycerol

DAC

dibenz(a,c)anthracene

DAH

dibenz(a,h)anthracene

DDT

dichlorodiphenyltrichloroethane

DMBA

7,12-dimethylbenz(a)anthracene

EGF

epidermal growth factor

EGFR

epidermal growth factor receptor

ER

estrogen receptor

121

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

GCR

G protein coupled receptor

GDP

guanosine 5’-diphosphate

GH

growth hormone

Grb2

growth factor receptor bound protein 2

GTP

guanosine 5’-triphosphate

HAH

halogenated aromatic hydrocarbons

HMEC

human mammary epithelial cells

IP3

inositol 1,4,5-trisphosphate

IGF

insulin-like growth factor

IGFBP

insulin-like growth factor binding proteins

IGF-IR

insulin-like growth factor receptor-I

IR

insulin receptor

IRS-1

insulin receptor substrate-1

IRS-2

insulin receptor substrate-2

MAPK

mitogen activated protein kinase

mSos

mammalian son of sevenless

PAH

polycyclic aromatic hydrocarbons

PCB

polychlorinated biphenyls

PI3K

phosphatidylinositol-3 kinase

PI 3-P

phosphatidylinositol 3-phosphate

PI 3,4-P2

phosphatidylinositol 3,4-bisphosphate

PI 3,4,5-Pj

phosphatidylinositol 3,4,5-trisphosphate
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PIP2

phosphoinositol 4,5-bisphosphate

PKB(Akt)

protein kinase B

PKC

protein kinase C

PLC

phospholipase C

PLC-yl

phospholipase C-yl

PTB

phosphotyrosine binding domain

PTP

protein tyrosine phosphatase

RTK

receptor tyrosine kinase

RMEC

rat mammary epithelial cells

SERCA

sarcoplasmic/endoplasmic reticulum calcium ATPase

SH2

sre homology domain 2

SH3

sre homology domain 3

She

sre homology 2/a-collagen related protein

SRE

serum response elements

TCDD

2,3,7,8-tetrachlorodibenzo-p-dioxin

TGF-a

transforming growth factor-a

TGF-P

transforming growth factor-p

TRE

TPA response elements

XRE

xenobiotic response element

3-MC

3-methylcholanthracene
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